

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>An update on the diagnosis and treatment of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-186/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-186" />
    
            <meta name="description" content="Read the original article in full on F1000Research: An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy" />
    
            <meta name="og:title" content="F1000Research Article: An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy.">
            <meta name="og:description" content="Read the latest article version by Shazli Azmi, Ioannis N. Petropoulos, Maryam Ferdousi, Georgios Ponirakis, Uazman Alam, Rayaz A. Malik, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="18716">
            <meta name="article-id" content="17118">
            <meta name="dc.title" content="An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy">
            <meta name="dc.description" content="Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes. It poses a significant challenge for clinicians as it is often diagnosed late when patients present with advanced consequences such as foot ulceration. Autonomic neuropathy (AN) is also a frequent and under-diagnosed complication unless it is overtly symptomatic. Both somatic and autonomic neuropathy are associated with increased mortality. Multiple clinical trials have failed because of limited efficacy in advanced disease, inadequate trial duration, lack of effective surrogate end-points and a lack of deterioration in the placebo arm in clinical trials of DPN. Multifactorial risk factor reduction, targeting glycaemia, blood pressure and lipids can reduce the progression of DPN and AN. Treatment of painful DPN reduces painful symptoms by about 50% at best, but there is limited efficacy with any single agent. This reflects the complex aetiology of painful DPN and argues for improved clinical phenotyping with the use of targeted therapy, taking into account co-morbid conditions such as anxiety, depression and sleep disturbance.">
            <meta name="dc.subject" content="diabetes mellitus, peripheral neuropathy, autonomic neuropathy">
            <meta name="dc.creator" content="Azmi, Shazli">
            <meta name="dc.creator" content="Petropoulos, Ioannis N.">
            <meta name="dc.creator" content="Ferdousi, Maryam">
            <meta name="dc.creator" content="Ponirakis, Georgios">
            <meta name="dc.creator" content="Alam, Uazman">
            <meta name="dc.creator" content="Malik, Rayaz A.">
            <meta name="dc.date" content="2019/02/15">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.17118.1">
            <meta name="dc.source" content="F1000Research 2019 8:186">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="diabetes mellitus">
            <meta name="prism.keyword" content="peripheral neuropathy">
            <meta name="prism.keyword" content="autonomic neuropathy">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/02/15">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="186">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.17118.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-186">
            <meta name="citation_title" content="An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy">
            <meta name="citation_abstract" content="Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes. It poses a significant challenge for clinicians as it is often diagnosed late when patients present with advanced consequences such as foot ulceration. Autonomic neuropathy (AN) is also a frequent and under-diagnosed complication unless it is overtly symptomatic. Both somatic and autonomic neuropathy are associated with increased mortality. Multiple clinical trials have failed because of limited efficacy in advanced disease, inadequate trial duration, lack of effective surrogate end-points and a lack of deterioration in the placebo arm in clinical trials of DPN. Multifactorial risk factor reduction, targeting glycaemia, blood pressure and lipids can reduce the progression of DPN and AN. Treatment of painful DPN reduces painful symptoms by about 50% at best, but there is limited efficacy with any single agent. This reflects the complex aetiology of painful DPN and argues for improved clinical phenotyping with the use of targeted therapy, taking into account co-morbid conditions such as anxiety, depression and sleep disturbance.">
            <meta name="citation_description" content="Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes. It poses a significant challenge for clinicians as it is often diagnosed late when patients present with advanced consequences such as foot ulceration. Autonomic neuropathy (AN) is also a frequent and under-diagnosed complication unless it is overtly symptomatic. Both somatic and autonomic neuropathy are associated with increased mortality. Multiple clinical trials have failed because of limited efficacy in advanced disease, inadequate trial duration, lack of effective surrogate end-points and a lack of deterioration in the placebo arm in clinical trials of DPN. Multifactorial risk factor reduction, targeting glycaemia, blood pressure and lipids can reduce the progression of DPN and AN. Treatment of painful DPN reduces painful symptoms by about 50% at best, but there is limited efficacy with any single agent. This reflects the complex aetiology of painful DPN and argues for improved clinical phenotyping with the use of targeted therapy, taking into account co-morbid conditions such as anxiety, depression and sleep disturbance.">
            <meta name="citation_keywords" content="diabetes mellitus, peripheral neuropathy, autonomic neuropathy">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Shazli Azmi">
            <meta name="citation_author_institution" content="Institute of Cardiovascular Sciences, University of Manchester and Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK">
            <meta name="citation_author_institution" content="Manchester Diabetes Centre, Manchester University Foundation Trust, Manchester, UK">
            <meta name="citation_author" content="Ioannis N. Petropoulos">
            <meta name="citation_author_institution" content="Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar">
            <meta name="citation_author" content="Maryam Ferdousi">
            <meta name="citation_author_institution" content="Institute of Cardiovascular Sciences, University of Manchester and Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK">
            <meta name="citation_author" content="Georgios Ponirakis">
            <meta name="citation_author_institution" content="Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar">
            <meta name="citation_author" content="Uazman Alam">
            <meta name="citation_author_institution" content="Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK">
            <meta name="citation_author_institution" content="Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK">
            <meta name="citation_author" content="Rayaz A. Malik">
            <meta name="citation_author_institution" content="Institute of Cardiovascular Sciences, University of Manchester and Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK">
            <meta name="citation_author_institution" content="Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar">
            <meta name="citation_publication_date" content="2019/02/15">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="186">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.17118.1">
            <meta name="citation_firstpage" content="186">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-186/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-186.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=18716 /> <input type=hidden id=articleId name=articleId value=17118 /> <input type=hidden id=xmlUrl value="/articles/8-186/v1/xml"/> <input type=hidden id=xmlFileName value="-8-186-v1.xml"> <input type=hidden id=article_uuid value=68f0bdfe-59f8-4901-9dc0-b8f205eab4cd /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.17118.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.17118.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-186"
  },
  "headline": "An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy",
  "datePublished": "2019-02-15T09:10:32",
  "dateModified": "2019-02-15T09:10:32",
  "author": [
    {
      "@type": "Person",
      "name": "Shazli Azmi"
    },    {
      "@type": "Person",
      "name": "Ioannis N. Petropoulos"
    },    {
      "@type": "Person",
      "name": "Maryam Ferdousi"
    },    {
      "@type": "Person",
      "name": "Georgios Ponirakis"
    },    {
      "@type": "Person",
      "name": "Uazman Alam"
    },    {
      "@type": "Person",
      "name": "Rayaz A. Malik"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes. It poses a significant challenge for clinicians as it is often diagnosed late when patients present with advanced consequences such as foot ulceration. Autonomic neuropathy (AN) is also a frequent and under-diagnosed complication unless it is overtly symptomatic. Both somatic and autonomic neuropathy are associated with increased mortality. Multiple clinical trials have failed because of limited efficacy in advanced disease, inadequate trial duration, lack of effective surrogate end-points and a lack of deterioration in the placebo arm in clinical trials of DPN. Multifactorial risk factor reduction, targeting glycaemia, blood pressure and lipids can reduce the progression of DPN and AN. Treatment of painful DPN reduces painful symptoms by about 50% at best, but there is limited efficacy with any single agent. This reflects the complex aetiology of painful DPN and argues for improved clinical phenotyping with the use of targeted therapy, taking into account co-morbid conditions such as anxiety, depression and sleep disturbance."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-186/v1",
            "name": "An update on the diagnosis and treatment of diabetic somatic and autonomic..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> An update on the diagnosis and treatment of diabetic somatic and autonomic... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=18716 data-id=17118 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17118.1" data-recommended="" data-doi="10.12688/f1000research.17118.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-186/v1/pdf?article_uuid=68f0bdfe-59f8-4901-9dc0-b8f205eab4cd" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-17118-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-17118-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-17118-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Azmi S, Petropoulos IN, Ferdousi M <em>et al.</em> An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):186 (<a class=new-orange href="https://doi.org/10.12688/f1000research.17118.1" target=_blank>https://doi.org/10.12688/f1000research.17118.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-17118-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=17118 id=track-article-signin-17118 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17118?target=/articles/8-186/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18716 /> <input name=articleId type=hidden value=17118 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Shazli Azmi<a href="https://orcid.org/0000-0002-1789-6988" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1789-6988</div><sup>1,2</sup>,&nbsp;</span><span class="">Ioannis N. Petropoulos<sup>3</sup>,&nbsp;</span><span class="">Maryam Ferdousi<sup>1</sup>,&nbsp;</span><span class="">Georgios Ponirakis<sup>3</sup>,&nbsp;</span><span class="">Uazman Alam<sup>4,5</sup>,&nbsp;</span><span class=""><a href="mailto:ram2045@qatar-med.cornell.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rayaz A. Malik</span></a><sup>1,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Shazli Azmi<a href="http://orcid.org/0000-0002-1789-6988" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1789-6988</div><sup>1,2</sup>,&nbsp;</span><span class="">Ioannis N. Petropoulos<sup>3</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Maryam Ferdousi<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Georgios Ponirakis<sup>3</sup>,&nbsp;</span><span class="">Uazman Alam<sup>4,5</sup>,&nbsp;</span><span class=""><a href="mailto:ram2045@qatar-med.cornell.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rayaz A. Malik</span></a><sup>1,3</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 15 Feb 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.17118.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Institute of Cardiovascular Sciences, University of Manchester and Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK<br/> <sup>2</sup> Manchester Diabetes Centre, Manchester University Foundation Trust, Manchester, UK<br/> <sup>3</sup> Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar<br/> <sup>4</sup> Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK<br/> <sup>5</sup> Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK<br/> <p> <div class=margin-bottom> Shazli Azmi <br/> <span>Roles: </span> Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ioannis N. Petropoulos <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Maryam Ferdousi <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Georgios Ponirakis <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Uazman Alam <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Rayaz A. Malik <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=45773-44099></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=45774-44098></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=45775-44097></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Diabetic peripheral neuropathy (DPN) is the most common chronic complication of diabetes. It poses a significant challenge for clinicians as it is often diagnosed late when patients present with advanced consequences such as foot ulceration. Autonomic neuropathy (AN) is also a frequent and under-diagnosed complication unless it is overtly symptomatic. Both somatic and autonomic neuropathy are associated with increased mortality. Multiple clinical trials have failed because of limited efficacy in advanced disease, inadequate trial duration, lack of effective surrogate end-points and a lack of deterioration in the placebo arm in clinical trials of DPN. Multifactorial risk factor reduction, targeting glycaemia, blood pressure and lipids can reduce the progression of DPN and AN. Treatment of painful DPN reduces painful symptoms by about 50% at best, but there is limited efficacy with any single agent. This reflects the complex aetiology of painful DPN and argues for improved clinical phenotyping with the use of targeted therapy, taking into account co-morbid conditions such as anxiety, depression and sleep disturbance. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> diabetes mellitus, peripheral neuropathy, autonomic neuropathy </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Rayaz A. Malik (<a href="mailto:ram2045@qatar-med.cornell.edu">ram2045@qatar-med.cornell.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Rayaz A. Malik </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Azmi S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Azmi S, Petropoulos IN, Ferdousi M <em>et al.</em> An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):186 (<a href="https://doi.org/10.12688/f1000research.17118.1" target=_blank>https://doi.org/10.12688/f1000research.17118.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 15 Feb 2019, <b>8</b>(F1000 Faculty Rev):186 (<a href="https://doi.org/10.12688/f1000research.17118.1" target=_blank>https://doi.org/10.12688/f1000research.17118.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 15 Feb 2019, <b>8</b>(F1000 Faculty Rev):186 (<a href="https://doi.org/10.12688/f1000research.17118.1" target=_blank>https://doi.org/10.12688/f1000research.17118.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e242>Diagnosing diabetic peripheral neuropathy: too little too late</h2><p class="" id=d9430e245>The early diagnosis and monitoring of diabetic peripheral neuropathy (DPN) are recommended by both the Toronto consensus<sup><a href="#ref-1">1</a></sup> and the more recent American Diabetes Association (ADA) position statement on DPN<sup><a href="#ref-2">2</a></sup>. They recommend the presence of at least one symptom or sign of neuropathy and abnormal neurophysiology for the diagnosis of DPN. Symptom questionnaires, composite neurological scores and quantitative sensory testing (QST) may be used to diagnose DPN (<a href="#T1">Table 1</a>). The neuropathy disability score<sup><a href="#ref-3">3</a></sup>, a composite measure of neurological deficits (based on Achilles tendon reflexes, 120-Hz vibration, temperature and pin-prick sensation); Toronto Clinical Neuropathy Score<sup><a href="#ref-4">4</a></sup>; and the Michigan Neuropathy Screening Instrument<sup><a href="#ref-5">5</a></sup> are validated neurological scores of clinical DPN. Although these tests are adequate tools to screen for DPN, they lack the sensitivity to assess change in clinical trials of relatively short duration (12–24 months). Yet they continue to be advocated as measures of efficacy, despite serial failure to show benefits in clinical trials of DPN.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Common tests for the assessment of neuropathy.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d9430e283 class=n-a></a><thead><a name=d9430e285 class=n-a></a><tr><a name=d9430e287 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e289 class=n-a></a>Type of nerve</th><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e292 class=n-a></a>Investigation</th><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e295 class=n-a></a>Advantages and disadvantages</th></tr></thead><tbody><a name=d9430e300 class=n-a></a><tr><a name=d9430e302 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e304 class=n-a></a>Large fibre</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e307 class=n-a></a>Nerve conduction studies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e310 class=n-a></a>Gold standard<br class=br>Sensitive, specific, and reproducible and easily standardised<br class=br>Must be done by trained professional</td></tr><tr><a name=d9430e318 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e320 class=n-a></a>Large and small fibres</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e323 class=n-a></a>Neuropathy disability score</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e326 class=n-a></a>Good predictor for risk of ulceration<br class=br>Subjective<br class=br>Does not detect sub-clinical large fibre damage</td></tr><tr><a name=d9430e334 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e336 class=n-a></a>Small fibre</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e339 class=n-a></a>Quantitative sensory testing</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e342 class=n-a></a>Reproducible and reliable<br class=br>Subjective</td></tr><tr><a name=d9430e348 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e350 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e352 class=n-a></a>Skin biopsy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e355 class=n-a></a>Gold standard for small fibre testing<br class=br>Reliable and reproducible<br class=br>Invasive procedure which needs specialised laboratory service</td></tr><tr><a name=d9430e363 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e365 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e367 class=n-a></a>Corneal confocal<br class=br>microscopy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e372 class=n-a></a>Rapid, reproducible, non-invasive<br class=br>Detects small fibre damage and tracks worsening and improvement in small<br class=br>phase 2b clinical trials<br class=br>Requires training to perform</td></tr></tbody></table></div><p class="" id=d9430e385>QST<sup><a href="#ref-6">6</a></sup> is a painless, non-invasive means to diagnose small and large fibre dysfunction and is based on impaired thermal, pain and vibration perception, respectively (<a href="#T1">Table 1</a>). Elevated vibration perception threshold is a risk factor for foot ulceration and lower-extremity amputation<sup><a href="#ref-7">7</a></sup> but is a subjective test<sup><a href="#ref-8">8</a></sup>. Light touch can be assessed by using the 10-g monofilament and is commonly advocated as a screening tool for DPN, although it can only detect advanced neuropathy<sup><a href="#ref-9">9</a></sup> and those at increased risk of amputation<sup><a href="#ref-10">10</a></sup>. Diagnosing established DPN is akin to ‘closing the stable door after the horse has bolted’.</p><p class="" id=d9430e412>Nerve conduction studies assess large fibre function and are currently advocated as the gold standard for a definite diagnosis of DPN<sup><a href="#ref-11">11</a></sup>. The typical electrophysiological findings in DPN are reduced amplitude of the compound muscle action potential, slower nerve conduction velocity, prolonged F-wave latency and an altered H-reflex. They are particularly useful for differentiating from other or concomitant neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP)<sup><a href="#ref-12">12</a></sup>. They are also advocated as a primary end-point to measure therapeutic effect but have equally failed in the majority of clinical trials of DPN<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d9430e428>Thus, several caveats ought to be carefully considered when these tests are employed to assess change over time and the response to therapies. Although composite scores and QST are resourceful methods to assess neuropathy, they have poor sensitivity and reproducibility<sup><a href="#ref-14">14</a></sup> and low histopathological specificity<sup><a href="#ref-15">15</a></sup>. They may be of value in large longitudinal cohort studies as opposed to individual patients or relatively small phase III clinical trials of short duration<sup><a href="#ref-14">14</a></sup>. Nerve conduction studies cannot assess small fibre neuropathy and have poor inter-rater reproducibility<sup><a href="#ref-16">16</a></sup>, making multi-centre trials difficult<sup><a href="#ref-17">17</a></sup>. Indeed, these measures have consistently failed to show meaningful improvements in clinical trials of neuropathy<sup><a href="#ref-18">18</a>–<a href="#ref-20">20</a></sup>.</p><p class="" id=d9430e459>Intra-epidermal nerve density (IENFD) evaluation in skin biopsy offers an objective and more reproducible means to assess small nerve fibre pathology<sup><a href="#ref-21">21</a></sup>. IENFD is reduced in pre-diabetes<sup><a href="#ref-22">22</a></sup>, predicts incident neuropathy<sup><a href="#ref-23">23</a></sup> and improves with lifestyle intervention<sup><a href="#ref-24">24</a></sup>. Unlike neurophysiology, skin biopsy is not confounded by height and weight, although a gender- and age-dependent decline has been reported<sup><a href="#ref-21">21</a></sup>. There are published guidelines on the use of skin biopsy to diagnose DPN<sup><a href="#ref-25">25</a></sup>. However, wider adoption of skin biopsy is limited by cost, the need for a dedicated processing and assessment facility, and the risk of bleeding and infection following the procedure. Corneal confocal microscopy (CCM) is a powerful, non-invasive ophthalmic imaging end-point for DPN and other neuropathies<sup><a href="#ref-26">26</a></sup>. CCM can be used to quantify small fibre pathology with high reproducibility<sup><a href="#ref-27">27</a></sup>. Corneal c-fibres form the sub-basal nerve plexus and are highly metabolically demanding<sup><a href="#ref-28">28</a></sup> and hence vulnerable even to transient and minor metabolic perturbation<sup><a href="#ref-22">22</a></sup>. Recent studies have established CCM values for the diagnosis<sup><a href="#ref-29">29</a>–<a href="#ref-31">31</a></sup> and prediction<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup> of DPN on the basis of corneal nerve fibre density and length<sup><a href="#ref-34">34</a>–<a href="#ref-37">37</a></sup>. CCM has also shown corneal nerve regeneration in clinical trials before change in other US Food and Drug Administration (FDA)-accepted end-points (for example, neurophysiology and skin biopsy), a finding which has important implications for clinical trial design<sup><a href="#ref-13">13</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e532>Disease modification for diabetic neuropathy</h2><p class="" id=d9430e535>In the 2017 ADA position statement on diabetic neuropathy, early recognition of DPN even in pre-diabetes is recommended<sup><a href="#ref-2">2</a>,<a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. There are no FDA-approved disease-modifying treatments for the management of DPN, and improved glycaemic control to prevent progression forms the mainstay of treatment. In type 1 diabetes mellitus (T1DM), improved glycaemic control can prevent the development and delay the progression of neuropathy<sup><a href="#ref-40">40</a></sup>. However, in T2DM, there is limited evidence that improved glycaemic control can slow down the progression of neuropathy<sup><a href="#ref-41">41</a>–<a href="#ref-43">43</a></sup>. The EURODIAB IDDM (European Diabetes Centers Study of Complications in Patients with Insulin-dependent Diabetes Mellitus), which evaluated over 3000 patients with T1DM for a duration of 7 years, identified poor glycaemic control, elevated low-density lipoprotein (LDL) cholesterol and triglycerides, hypertension, obesity and smoking as risk factors for incident DPN<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d9430e563>In patients with T1DM, treatment with an angiotensin-converting enzyme (ACE) inhibitor<sup><a href="#ref-45">45</a></sup> or in combination with a calcium channel blocker<sup><a href="#ref-46">46</a></sup> has been shown to improve DPN in randomised placebo-controlled trials<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. Statins and fibrates have also been shown to prevent the development of DPN<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup> and have been associated with reduced diabetic foot infection<sup><a href="#ref-51">51</a></sup> and lower-extremity amputation<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup> and increased rate of foot ulcer healing<sup><a href="#ref-54">54</a></sup>. Recent experimental studies advocate the use of combination therapies targeting several pathogenetic pathways as the most effective approach to the treatment of DPN<sup><a href="#ref-55">55</a>–<a href="#ref-57">57</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e614>Painful diabetic peripheral neuropathy</h2><div class=section><a name=d9430e617 class=n-a></a><h3 class=section-title>Diagnosis of painful diabetic peripheral neuropathy</h3><p class="" id=d9430e622>Painful diabetic peripheral neuropathy (PDPN) is a manifestation of small fibre damage<sup><a href="#ref-58">58</a>–<a href="#ref-60">60</a></sup>, characterised by burning pain and tingling with nocturnal exacerbation. It has a significant impact on the patient’s quality of life<sup><a href="#ref-61">61</a>–<a href="#ref-63">63</a></sup> and can result in depression, anxiety and sleep disturbance<sup><a href="#ref-62">62</a></sup>. Estimates of the prevalence of PDPN range from 14.0 to 65.3%<sup><a href="#ref-61">61</a>,<a href="#ref-64">64</a>–<a href="#ref-69">69</a></sup> (<a href="#f1">Figure 1</a>). This difference can be attributed to different populations studied and different diagnostic methods. The prevalence of PDPN is higher in secondary compared with primary care<sup><a href="#ref-70">70</a></sup> and in patients with T2DM compared with T1DM<sup><a href="#ref-61">61</a>,<a href="#ref-64">64</a>,<a href="#ref-71">71</a></sup>. It is important to note that for a large proportion (12.5–61.5%) of patients, PDPN remains undiagnosed<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>. They are often unaware that the pain is related to diabetes and do not report it to their clinician<sup><a href="#ref-72">72</a></sup>. Older age, longer duration of diabetes, and the presence of DPN increase the risk for PDPN<sup><a href="#ref-61">61</a>,<a href="#ref-64">64</a>–<a href="#ref-66">66</a>,<a href="#ref-68">68</a></sup>; and obesity<sup><a href="#ref-61">61</a>,<a href="#ref-65">65</a>,<a href="#ref-70">70</a>,<a href="#ref-71">71</a></sup>, low physical activity<sup><a href="#ref-24">24</a>,<a href="#ref-67">67</a></sup>, smoking<sup><a href="#ref-64">64</a>,<a href="#ref-70">70</a></sup>, poor glycaemic control<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>, low high-density lipoprotein (HDL) cholesterol<sup><a href="#ref-61">61</a></sup>, and raised LDL cholesterol, triglycerides and creatinine<sup><a href="#ref-67">67</a></sup> are independent risk factors for PDPN. Early diagnosis and intervention may be the key, as a study of subjects with pre-diabetes showed that lifestyle intervention reduced neuropathic symptoms and improved small fibre function and structure<sup><a href="#ref-24">24</a></sup>. Therefore, actively screening patients for PDPN, particularly those at high risk, should allow early identification and symptom relief but may also enable timely disease modification.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/18716/ebc8eb1f-2139-4b4c-aac6-1f33c0cb185e_figure1.gif"><img alt="ebc8eb1f-2139-4b4c-aac6-1f33c0cb185e_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/18716/ebc8eb1f-2139-4b4c-aac6-1f33c0cb185e_figure1.gif"></a><div class=caption><h3>Figure 1. Prevalence of painful diabetic peripheral neuropathy (PDPN) reported from different countries ranges from 14.0 to 65.3%<sup><a href="#ref-61">61</a>,<a href="#ref-64">64</a>–<a href="#ref-69">69</a></sup>.</h3></div></div><p class="" id=d9430e766>There are several screening tests that distinguish nociceptive and neuropathic pain. The most common screening tests for PDPN are the Douleur Neuropathique 4 (DN4) questionnaire<sup><a href="#ref-75">75</a></sup>, the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale<sup><a href="#ref-76">76</a></sup> and the Neuropathic Pain Questionnaire (NPQ)<sup><a href="#ref-77">77</a></sup>. The DN4 is composed of 10 questions (seven symptoms and three neurological deficits), and a score of at least 4 has a high sensitivity (83%) and specificity (90%) for PDPN<sup><a href="#ref-78">78</a></sup>. The LANSS pain scale is composed of five questions on symptoms and two on neurological deficits, and a score at least 12 has a 85% sensitivity and 80% specificity for PDPN<sup><a href="#ref-76">76</a></sup>. The NPQ contains 10 questions on quality of pain and two on change in sensation<sup><a href="#ref-77">77</a></sup> and detects PDPN with 74.7% sensitivity and 77.6% specificity.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e798>Treatment of painful diabetic peripheral neuropathy</h2><p class="" id=d9430e801>There is no evidence that improvement in glycaemic control improves PDPN; indeed, where rapid and large reductions in HbA1c may precipitate an acute painful neuropathy, the opposite is true<sup><a href="#ref-79">79</a></sup>. The traditional approach to managing PDPN is to try different therapies until one works (with minimal side effects). However, improved clinical phenotyping and targeting of therapies based on underlying mechanism(s) may result in better outcomes<sup><a href="#ref-80">80</a></sup>. Detailed phenotyping using QST suggests that in patients with an irritable nociceptor compared with a non-irritable nociceptor phenotype, there is a better response to oxcarbazepine, with a number needed to treat (NNT) of 3.9 compared with 6.9 in those with the non-irritable nociceptor<sup><a href="#ref-81">81</a></sup>. Identifying abnormalities in rate-dependent depression (RDD), a marker of altered descending inhibitory modulation of pain, may also help to identify patients who will respond optimally to selective norepinephrine reuptake inhibitors for example, duloxetine<sup><a href="#ref-82">82</a></sup>.</p><p class="" id=d9430e820>Tricyclic anti-depressants (TCAs) modulate pain and have analgesic efficacy by indirectly modifying the opioid system in the brain and via serotonergic and noradrenaline neuromodulation, amongst other mechanisms<sup><a href="#ref-83">83</a>–<a href="#ref-85">85</a></sup>. Amitriptyline is the most commonly used TCA in PDPN, despite not having a label for its treatment. In a systematic review, Moore <i>et al</i>.<sup><a href="#ref-86">86</a></sup> evaluated 17 studies with 1342 participants and concluded that study quality was modest, and most studies had a high risk of bias due to the small participant numbers<sup><a href="#ref-86">86</a></sup>. Two serotonin and norepinephrine reuptake inhibitors (SNRIs) are recommended for PDPN: duloxetine and venlafaxine. They exert their effect via inhibiting serotonin and noradrenaline reuptake with potentiation of descending inhibitory pathways<sup><a href="#ref-87">87</a></sup>. A Cochrane review including eight randomised controlled trials (n = 2728) showed that duloxetine 60 mg daily was superior to placebo, and the NNT was 5<sup><a href="#ref-88">88</a></sup>. Pregabalin also has FDA approval for PDPN on the basis of a number of randomised controlled trials (RCTs)<sup><a href="#ref-89">89</a>–<a href="#ref-91">91</a></sup>. Snedecor <i>et al</i>. undertook a comparative meta-analysis of a number of agents to treat PDPN and found pregabalin to be the most efficacious in reducing Visual Analogue Scale (VAS) pain scores<sup><a href="#ref-92">92</a></sup>. Duloxetine and pregabalin are both considered first-line therapy by National Institute for Clinical Excellence (NICE) and the 2017 ADA position statement<sup><a href="#ref-2">2</a>,<a href="#ref-93">93</a></sup>. Mirogabalin has also recently shown efficacy and good tolerability in a phase II and two phase III clinical trials in PDPN<sup><a href="#ref-94">94</a>–<a href="#ref-96">96</a></sup>. Tramadol has an opioid plus SNRI effect. A Cochrane Collaboration review found that the efficacy of tramadol in neuropathic pain was determined in small, inadequately sized studies with a risk of bias<sup><a href="#ref-97">97</a></sup>, although a meta-analysis showed an NNT of 4.4. Tapentadol extended-release has also shown efficacy in a number of randomised clinical trials and is recommended by the FDA in PDPN<sup><a href="#ref-98">98</a>–<a href="#ref-101">101</a></sup>.</p><p class="" id=d9430e890>The COMBO-DN (Combination versus Monotherapy of pregabalin and duloxetine in Diabetic Neuropathy) study compared monotherapy with a combination of duloxetine and pregabalin<sup><a href="#ref-102">102</a></sup>. The pain outcomes between combination (duloxetine 60 mg daily plus pregabalin 300 mg daily) and high-dose monotherapy (duloxetine 120 mg daily or pregabalin 600 mg daily) were comparable<sup><a href="#ref-102">102</a></sup>. In an exploratory post-hoc analysis, high-dose monotherapy was more favourable in patients with severe pain, whereas combination therapy was more beneficial in patients with mild to moderate pain<sup><a href="#ref-103">103</a></sup>. In a double-blind RCT with a parallel-group design, analgesic efficacy was found to be comparable between amitriptyline, duloxetine and pregabalin<sup><a href="#ref-104">104</a></sup>.</p><p class="" id=d9430e909>In patients presenting with PDPN, the key is to provide symptom relief, but we would argue that this also represents a window of opportunity for risk factor reduction to limit DPN progression. For symptom relief, pregabalin, gabapentin, duloxetine or amitriptyline can be used first line, and if they are not working or have limited effectiveness because of side effects, then a second-line agent or tramadol can be added in combination (<a href="#T2">Table 2</a>). Topical therapies such as a glyceryl trinitrate (GTN) spray<sup><a href="#ref-105">105</a></sup> or patch<sup><a href="#ref-106">106</a></sup> applied to the feet can be considered and give a favourable NNT of about 4<sup><a href="#ref-107">107</a>,<a href="#ref-108">108</a></sup>. There is an evolving argument that the future management of PDPN will follow a more personalised approach using markers such as RDD<sup><a href="#ref-109">109</a></sup>, CCM<sup><a href="#ref-110">110</a></sup> and genomics<sup><a href="#ref-111">111</a>–<a href="#ref-113">113</a></sup> to identify specific mechanisms in patients who will respond better to targeted therapies.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Commonly used therapy for painful diabetic peripheral neuropathy.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d9430e958 class=n-a></a><thead><a name=d9430e960 class=n-a></a><tr><a name=d9430e962 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e964 class=n-a></a>Drug class</th><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e967 class=n-a></a>Agent</th><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e970 class=n-a></a>Initial dose</th><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e973 class=n-a></a>Maintenance dose</th><th align=left colspan=1 rowspan=1 valign=top><a name=d9430e976 class=n-a></a>Comments and common adverse reactions</th></tr></thead><tbody><a name=d9430e981 class=n-a></a><tr><a name=d9430e983 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d9430e985 class=n-a></a>Anticonvulsants</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e988 class=n-a></a>Pregabalin<sup><a href="#ref-89">89</a>–<a href="#ref-92">92</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e997 class=n-a></a>25–75 mg three times<br class=br>a day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1002 class=n-a></a>300–600 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1005 class=n-a></a>Adverse events (AEs): dizziness, somnolence, headache and weight gain<br class=br><br class=br>Approved for the treatment of painful diabetic peripheral neuropathy (DPN)<br class=br><br class=br>Psychological dependence</td></tr><tr><a name=d9430e1015 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1017 class=n-a></a>Gabapentin<sup><a href="#ref-128">128</a>,<a href="#ref-129">129</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1026 class=n-a></a>100–300 mg three<br class=br>times a day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1031 class=n-a></a>900–3600 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1034 class=n-a></a>AEs: dizziness, somnolence, ataxia and fatigue<br class=br><br class=br>Reduce dose if estimated glomerular filtration rate is less than 60 mL/min.</td></tr><tr><a name=d9430e1041 class=n-a></a><td align=left colspan=1 rowspan=3 valign=top><a name=d9430e1043 class=n-a></a>Antidepressants</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1046 class=n-a></a>Duloxetine<sup><a href="#ref-88">88</a>,<a href="#ref-130">130</a>–<a href="#ref-132">132</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1058 class=n-a></a>20–30 mg once daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1061 class=n-a></a>60–120 mg once daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1064 class=n-a></a>Approved for the treatment of painful DPN<br class=br><br class=br>AEs: somnolence, dizziness, headache, nausea, dry mouth and reduced appetite<br class=br><br class=br>Avoid in hepatic impairment; avoid with creatinine clearance of less than 30 mL/min.</td></tr><tr><a name=d9430e1074 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1076 class=n-a></a>Venlafaxine<sup><a href="#ref-133">133</a>,<a href="#ref-134">134</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1085 class=n-a></a>37.5 mg once daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1088 class=n-a></a>75–225 mg once daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1091 class=n-a></a>AEs: nausea, dizziness, constipation, dry mouth, weight loss and constipation</td></tr><tr><a name=d9430e1095 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1097 class=n-a></a>Amitriptyline<sup><a href="#ref-83">83</a>,<a href="#ref-86">86</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1106 class=n-a></a>10–25 mg once daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1109 class=n-a></a>25–100 mg once daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1112 class=n-a></a>AEs: abdominal pain, headaches, dizziness, insomnia, orthostatic hypotension, anorexia,<br class=br>nausea, urinary retention, constipation, blurred vision, mydriasis, weight gain, xerostomia<br class=br>and somnolence<br class=br><br class=br>Avoid use in patients older than 60 years of age.</td></tr><tr><a name=d9430e1124 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d9430e1126 class=n-a></a>Opioid-like agonists</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1129 class=n-a></a>Tramadol<sup><a href="#ref-97">97</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1135 class=n-a></a>50 mg four times a<br class=br>day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1140 class=n-a></a>200–400 mg four<br class=br>times a day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1145 class=n-a></a>AEs: constipation, somnolence, nausea, headache and dizziness</td></tr><tr><a name=d9430e1149 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1151 class=n-a></a>Tapentadol<sup><a href="#ref-98">98</a>–<a href="#ref-101">101</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1160 class=n-a></a>50–100 mg four to six<br class=br>times per day;<br class=br>can take 700 mg on<br class=br>first day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1169 class=n-a></a>600 mg daily</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1172 class=n-a></a>AEs: nausea, dizziness, somnolence, constipation, vomiting and headache<br class=br><br class=br>Potential for addiction, abuse and misuse</td></tr><tr><a name=d9430e1179 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1181 class=n-a></a>Topical therapies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1184 class=n-a></a>Capsaicin 0.0075%<br class=br>cream<sup><a href="#ref-135">135</a>–<a href="#ref-138">138</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1195 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1197 class=n-a></a>Applied three or four<br class=br>times per day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1202 class=n-a></a>Can be used as an adjunct to oral therapies<br class=br><br class=br>Use is limited by the frequency of application.<br class=br>Cause denervation, hence may increase risk of foot ulceration</td></tr><tr><a name=d9430e1211 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1213 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1215 class=n-a></a>Lidocaine 5%<br class=br>plaster<sup><a href="#ref-92">92</a>,<a href="#ref-139">139</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1226 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1228 class=n-a></a>5% for up to 18 hours<br class=br>per day</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1233 class=n-a></a>AEs: application site reactions; otherwise, has fewer side effects than systemic agents<br class=br><br class=br>Can be used as an adjunct to oral therapies</td></tr><tr><a name=d9430e1240 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1242 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1244 class=n-a></a>Isosorbide<br class=br>dinitrate<sup><a href="#ref-106">106</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1252 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1254 class=n-a></a>Patch (5 mg) applied<br class=br>at bedtime to the<br class=br>bottom of the feet</td><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1261 class=n-a></a>AEs: headache. The dose can be halved if this occurs.</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1271>Cardiac autonomic neuropathy</h2><p class="" id=d9430e1274>The Toronto consensus panel defined cardiac autonomic neuropathy (CAN) as the impairment of cardiovascular autonomic control in patients with diabetes mellitus after the exclusion of other causes<sup><a href="#ref-114">114</a></sup>. CAN occurs in subjects with impaired glucose tolerance (IGT), and abnormal cardiovascular autonomic reflex tests (CARTs) have been reported in up to 7% of patients at diagnosis of T1DM and T2DM<sup><a href="#ref-115">115</a>–<a href="#ref-117">117</a></sup> with the prevalence increasing to 30% (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, or DCCT/EDIC) after 14 years of T1DM<sup><a href="#ref-118">118</a>,<a href="#ref-119">119</a></sup> and in other studies to 70% after 15 years<sup><a href="#ref-120">120</a></sup>. CAN is an independent risk factor for mortality<sup><a href="#ref-114">114</a></sup> and was the strongest risk factor for all-cause mortality in the EURODIAB study (T1DM) and an independent risk factor for mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study (T2DM)<sup><a href="#ref-121">121</a>,<a href="#ref-122">122</a></sup>. A meta-analysis of 15 longitudinal studies reported an association between CAN and increased mortality<sup><a href="#ref-123">123</a></sup>. A meta-analysis of 12 studies identified silent myocardial ischaemia (SMI) in 20% of patients with CAN compared with 10% in those without CAN<sup><a href="#ref-117">117</a></sup>. CAN is also associated with left ventricular dysfunction<sup><a href="#ref-124">124</a>,<a href="#ref-125">125</a></sup> and independently predicts the progression of diabetic nephropathy<sup><a href="#ref-126">126</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1334>Diagnosis of cardiac autonomic neuropathy</h2><p class="" id=d9430e1337>Screening for CAN is recommended at diagnosis in patients with T2DM and after 5 years for those with T1DM. Signs and symptoms of CAN should be assessed in patients with microvascular complications and in patients with hypoglycaemia unawareness<sup><a href="#ref-2">2</a>,<a href="#ref-127">127</a></sup>. The diagnosis of CAN includes the documentation of the symptoms and signs (<a href="#T3">Table 3</a>), but there is a weak correlation between symptoms and autonomic deficits<sup><a href="#ref-120">120</a>,<a href="#ref-140">140</a></sup> and symptoms may be subtle like intermittent palpitations and exercise intolerance. CAN may initially be asymptomatic with the only sign being decreased heart rate variability with deep breathing, which can progress to a resting tachycardia (&gt;100 bpm). In patients who are symptomatic (resting tachycardia with a history of poor glucose control) or where the diagnosis of CAN is very likely, the ADA position statement advises no additional testing<sup><a href="#ref-2">2</a></sup>. It is important to exclude other causes such as idiopathic orthostatic hypotension (OH), syncope and postural orthostatic tachycardia syndrome (POTS)<sup><a href="#ref-141">141</a></sup>. CARTs includes heart rate response to deep breathing, standing and the Valsalva manoeuvre.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Symptoms and signs of diabetic autonomic neuropathy.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d9430e1376 class=n-a></a><tbody><a name=d9430e1378 class=n-a></a><tr><a name=d9430e1380 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d9430e1382 class=n-a></a><b>Cardiac autonomic neuropathy</b><br class=br>•&nbsp;&nbsp;Resting tachycardia or fixed heart rate or both<br class=br>•&nbsp;&nbsp;Loss of circadian rhythm of blood pressure<br class=br>•&nbsp;&nbsp;Increase in nocturnal systolic blood pressure compared with daytime<br class=br>•&nbsp;&nbsp;Orthostatic hypotension<br class=br>•&nbsp;&nbsp;Exercise intolerance<br class=br>•&nbsp;&nbsp;Syncope and light headedness<br class=br>•&nbsp;&nbsp;Intra-operative cardiovascular lability<br class=br>•&nbsp;&nbsp;‘Silent ischemia’ and ‘painless’ myocardial infarction<br class=br>•&nbsp;&nbsp;Arrhythmias<br class=br><br class=br>•&nbsp;&nbsp;<b>Urogenital autonomic neuropathy</b><br class=br>Bladder dysfunction<br class=br>•&nbsp;&nbsp;Increase in frequency and urgency particularly during the night<br class=br>•&nbsp;&nbsp;Urinary hesitancy and weak stream<br class=br>•&nbsp;&nbsp;Dribbling of urine and involuntary urination<br class=br>•&nbsp;&nbsp;Urinary incontinence<br class=br>Sexual dysfunction<br class=br>•&nbsp;&nbsp;Male: erectile dysfunction, decreased libido and abnormal ejaculation<br class=br>•&nbsp;&nbsp;Female: decreased sexual desire and arousal, increased pain during intercourse and inadequate lubrication<br class=br><br class=br><b>Gastrointestinal autonomic neuropathy</b><br class=br>•&nbsp;&nbsp;Nausea/vomiting<br class=br>•&nbsp;&nbsp;Bloating<br class=br>•&nbsp;&nbsp;Inability to eat a full meal<br class=br>•&nbsp;&nbsp;Profuse and watery diarrhoea (nocturnal)<br class=br>•&nbsp;&nbsp;Constipation</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1450>Management of autonomic neuropathy</h2><p class="" id=d9430e1453>Poor glycaemic control and longer diabetes duration are established risk factors for CAN<sup><a href="#ref-42">42</a>,<a href="#ref-118">118</a>,<a href="#ref-119">119</a></sup>. The DCCT showed that intensive glycaemic control in patients with T1DM reduced the development of CAN by 45%<sup><a href="#ref-118">118</a></sup>. Hypertension, obesity, hyperlipidemia and smoking have also been implicated in the development of CAN<sup><a href="#ref-42">42</a>,<a href="#ref-117">117</a>,<a href="#ref-120">120</a>,<a href="#ref-142">142</a>–<a href="#ref-144">144</a></sup>, and the Steno-2 trial showed that intensified multifactorial treatment in patients with T2DM reduced the risk of CAN progression by 68%<sup><a href="#ref-145">145</a>,<a href="#ref-146">146</a></sup>. There are no FDA-approved disease-modifying treatments to reverse CAN. A small early study found favourable effects of alpha-lipoic acid (ALA) on CAN<sup><a href="#ref-147">147</a></sup>, however, more recently a study to evaluate triple anti-oxidant therapy (allopurinol (300 mg once daily), ALA (600 mg twice daily) and nicotinamide (750 mg twice daily)) in patients with mild to moderate CAN found no benefit<sup><a href="#ref-148">148</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1505>Orthostatic hypotension</h2><p class="" id=d9430e1508>Symptoms of OH occur on standing and include light-headedness, weakness, faintness and syncope. OH is defined by a blood pressure decrease on standing of greater than 20/10 mm Hg (a decrease of greater than 30/15 for those with blood pressure of greater than 150/90) without an appropriate increase in heart rate (&lt;15 bpm)<sup><a href="#ref-149">149</a></sup>. Treatment of OH involves a review of medication, fluid and salt repletion and encouragement of physical activity and exercise to avoid deconditioning<sup><a href="#ref-150">150</a>,<a href="#ref-151">151</a></sup>. Fludrocortisone is not FDA-approved for OH. It works through sodium retention and constriction of partially denervated blood vessels, but there are concerns over supine hypertension, hypokalaemia, congestive cardiac failure and peripheral oedema<sup><a href="#ref-152">152</a></sup>. Both midodrine and droxidopa are approved by the FDA for the treatment of symptomatic neurogenic OH<sup><a href="#ref-153">153</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1533>Gastroparesis</h2><p class="" id=d9430e1536>Gastroparesis is defined as the delayed removal of stomach contents in the absence of a physical obstruction<sup><a href="#ref-154">154</a></sup>. Gastric emptying should be assessed with scintigraphy 4 hours after food intake of digestible solids at 15-min intervals. Dietary modification with frequent small meals and prokinetics are recommended to increase gastric motility. Metoclopramide is the only FDA-approved drug for the treatment of gastroparesis. However, limited efficacy and the risk of tardive dyskinesia have led the FDA and European Medicines Agency to advise use for a maximum of 5 days. New therapies are being investigated and include motilin receptor agonists, ghrelin receptor agonists, and neurokinin receptor antagonists. Mechanical options for intervention include transpyloric stenting, gastric electrical stimulation, and gastric per-oral endoscopic myotomy; in severe intractable gastroparesis, laparoscopic pyloroplasty or gastrectomy may be options<sup><a href="#ref-155">155</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1550>Diabetic diarrhoea</h2><p class="" id=d9430e1553>Diabetic diarrhoea is a troublesome gastrointestinal complication which is characterised by watery painless diarrhoea, particularly at night. Other causes of diarrhoea must be excluded, especially therapy with metformin which is often overlooked, and pancreatic exocrine insufficiency (faecal fat of greater than 6 g/72 hours). Pharmacological therapies include antidiarrhoeal agents (for example, Lomotil or Imodium), antibiotics (tetracycline or metronidazole) to eradicate bacterial overgrowth, somatostatin analogues (octreotide), and selective serotonin 5-hydroxy tryptamine type 3 (HT3) receptor antagonists (Ramosetron)<sup><a href="#ref-156">156</a>,<a href="#ref-157">157</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1566>Bladder disturbance</h2><p class="" id=d9430e1569>Bladder dysfunction may occur in up to 50% of patients with diabetes due to urogenital autonomic neuropathy<sup><a href="#ref-141">141</a></sup>. The earliest manifestation includes increased initiating threshold for the micturition reflex followed by decreased detrusor activity and incomplete bladder emptying. Treatment includes suprapubic pressure, antimuscarinic medication (oxybutynin 5–30 mg 3 times a day; tolterodine 2–8 mg twice a day) for detrusor hyperreflexia and parasympathomimetic medication to reduce detrusor contractility, and intermittent self-catheterisation<sup><a href="#ref-2">2</a></sup>. It is important to note that none of the medications are FDA-approved for neurogenic bladder and they have approval only for non-neurogenic overactive bladder or other lower urinary tract symptoms.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d9430e1584>Erectile dysfunction</h2><p class="" id=d9430e1587>Erectile dysfunction (ED) is a common manifestation in men with diabetes<sup><a href="#ref-141">141</a></sup>. It may be three times more prevalent, occur 10 to 15 years earlier and is more severe and less responsive to treatment compared with those without diabetes<sup><a href="#ref-158">158</a></sup>. ED is associated with a higher HbA1c, presence of metabolic syndrome, hypertension, atherogenic dyslipidemia, lower estimated glomerular filtration rate, higher albumin/creatinine ratio and more severe small fibre neuropathy in men with T1DM<sup><a href="#ref-159">159</a>–<a href="#ref-161">161</a></sup>. Sexual dysfunction is also more common in women with diabetes, and 47% of women with diabetic neuropathy had sexual dysfunction<sup><a href="#ref-162">162</a></sup>. Reduced sexual arousal, decreased lubrication and painful intercourse are the most common symptoms of sexual dysfunction in females with diabetes. Recent recommendations include active smoking cessation (improves ED by about 30%), treatment of those with testosterone deficiency and treatment with statins. 5-phosphodiesterase inhibitors, intra-cavernosal and transurethral prostaglandins, and penile implants can be used for more severe cases<sup><a href="#ref-163">163</a>–<a href="#ref-165">165</a></sup>. There is about a 50% non-responder rate in patients with diabetes as they are less likely to respond to PDE5 inhibitors<sup><a href="#ref-166">166</a></sup>. Additional modalities such as low-intensity extracorporeal shock wave therapy show promise<sup><a href="#ref-167">167</a>–<a href="#ref-169">169</a></sup> but require larger and better designed clinical trials. There are several explanations for the lack of response<sup><a href="#ref-166">166</a></sup>, but it may also reflect a more severe neurogenic component to ED in these patients<sup><a href="#ref-159">159</a></sup>. Indeed, in a recent study, the assessment of nocturnal penile tumescence and rigidity, which reflects predominantly neurogenic abnormalities, had an area under the curve (AUC) of 0.860 in differentiating sildenafil responders from non-responders<sup><a href="#ref-170">170</a></sup>.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d9430e1 class=n-a></a><h2 class=main-title id=d9914>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d9430e1644 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d10465>References</h2><div class="section ref-list"><a name=d9430e1644 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d9430e1651 class=n-a></a>Tesfaye S, Boulton AJ, Dyck PJ, <i> et al.</i>: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. <i>Diabetes Care.</i> 2010; <b>33</b>(10): 2285–93. <a target=xrefwindow id=d9430e1662 href="http://www.ncbi.nlm.nih.gov/pubmed/20876709">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1665 href="https://doi.org/10.2337/dc10-1303">Publisher Full Text </a> | <a target=xrefwindow id=d9430e1669 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2945176">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d9430e1678 class=n-a></a>Pop-Busui R, Boulton AJ, Feldman EL, <i> et al.</i>: Diabetic Neuropathy: A Position Statement by the American Diabetes Association. <i>Diabetes Care.</i> 2017; <b>40</b>(1): 136–54. <a target=xrefwindow id=d9430e1689 href="http://www.ncbi.nlm.nih.gov/pubmed/27999003">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1692 href="https://doi.org/10.2337/dc16-2042">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d9430e1701 class=n-a></a>Young MJ, Boulton AJ, Macleod AF, <i> et al.</i>: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. <i>Diabetologia.</i> 1993; <b>36</b>(2): 150–4. <a target=xrefwindow id=d9430e1712 href="http://www.ncbi.nlm.nih.gov/pubmed/8458529">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1715 href="https://doi.org/10.1007/BF00400697">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d9430e1724 class=n-a></a>Perkins BA, Olaleye D, Zinman B, <i> et al.</i>: Simple screening tests for peripheral neuropathy in the diabetes clinic. <i>Diabetes Care.</i> 2001; <b>24</b>(2): 250–6. <a target=xrefwindow id=d9430e1735 href="http://www.ncbi.nlm.nih.gov/pubmed/11213874">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1738 href="https://doi.org/10.2337/diacare.24.2.250">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d9430e1747 class=n-a></a>Herman WH, Pop-Busui R, Braffett BH, <i> et al.</i>: Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. <i>Diabet Med.</i> 2012; <b>29</b>(7): 937–44. <a target=xrefwindow id=d9430e1758 href="http://www.ncbi.nlm.nih.gov/pubmed/22417277">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1761 href="https://doi.org/10.1111/j.1464-5491.2012.03644.x">Publisher Full Text </a> | <a target=xrefwindow id=d9430e1765 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3641573">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4204956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e1775 class=n-a></a>Maier C, Baron R, Tölle TR, <i> et al.</i>: Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. <i>Pain.</i> 2010; <b>150</b>(3): 439–50. <a target=xrefwindow id=d9430e1786 href="http://www.ncbi.nlm.nih.gov/pubmed/20627413">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1789 href="https://doi.org/10.1016/j.pain.2010.05.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4204956">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d9430e1802 class=n-a></a>Young MJ, Breddy JL, Veves A, <i> et al.</i>: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. <i>Diabetes Care.</i> 1994; <b>17</b>(6): 557–60. <a target=xrefwindow id=d9430e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/8082524">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1816 href="https://doi.org/10.2337/diacare.17.6.557">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d9430e1825 class=n-a></a>Martin CL, Waberski BH, Pop-Busui R, <i> et al.</i>: Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. <i>Diabetes Care.</i> 2010; <b>33</b>(12): 2635–41. <a target=xrefwindow id=d9430e1836 href="http://www.ncbi.nlm.nih.gov/pubmed/20833868">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1839 href="https://doi.org/10.2337/dc10-0616">Publisher Full Text </a> | <a target=xrefwindow id=d9430e1843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2992204">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d9430e1852 class=n-a></a>Tan LS: The clinical use of the 10g monofilament and its limitations: a review. <i>Diabetes Res Clin Pract.</i> 2010; <b>90</b>(1): 1–7. <a target=xrefwindow id=d9430e1860 href="http://www.ncbi.nlm.nih.gov/pubmed/20655123">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1863 href="https://doi.org/10.1016/j.diabres.2010.06.021">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d9430e1872 class=n-a></a>Rith-Najarian SJ, Stolusky T, Gohdes DM: Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. <i>Diabetes Care.</i> 1992; <b>15</b>(10): 1386–9. <a target=xrefwindow id=d9430e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/1425105">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1883 href="https://doi.org/10.2337/diacare.15.10.1386">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d9430e1892 class=n-a></a>Dyck PJ, Overland CJ, Low PA, <i> et al.</i>: Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. <i>Muscle Nerve.</i> 2010; <b>42</b>(2): 157–64. <a target=xrefwindow id=d9430e1903 href="http://www.ncbi.nlm.nih.gov/pubmed/20658599">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1906 href="https://doi.org/10.1002/mus.21661">Publisher Full Text </a> | <a target=xrefwindow id=d9430e1910 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2956592">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d9430e1920 class=n-a></a>Rajabally YA, Stettner M, Kieseier BC, <i> et al.</i>: CIDP and other inflammatory neuropathies in diabetes - diagnosis and management. <i>Nat Rev Neurol.</i> 2017; <b>13</b>(10): 599–611. <a target=xrefwindow id=d9430e1931 href="http://www.ncbi.nlm.nih.gov/pubmed/28914883">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1934 href="https://doi.org/10.1038/nrneurol.2017.123">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d9430e1943 class=n-a></a>Malik RA: Wherefore Art Thou, O Treatment for Diabetic Neuropathy? <i>Int Rev Neurobiol.</i> 2016; <b>127</b>: 287–317. <a target=xrefwindow id=d9430e1951 href="http://www.ncbi.nlm.nih.gov/pubmed/27133154">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1954 href="https://doi.org/10.1016/bs.irn.2016.03.008">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d9430e1963 class=n-a></a>Shy ME, Frohman EM, So YT, <i> et al.</i>: Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. <i>Neurology.</i> 2003; <b>60</b>(6): 898–904. <a target=xrefwindow id=d9430e1974 href="http://www.ncbi.nlm.nih.gov/pubmed/12654951">PubMed Abstract </a> | <a target=xrefwindow id=d9430e1977 href="https://doi.org/10.1212/01.WNL.0000058546.16985.11">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d9430e1986 class=n-a></a>Løseth S, Stålberg E, Jorde R, <i> et al.</i>: Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. <i>J Neurol.</i> 2008; <b>255</b>(8): 1197–202. <a target=xrefwindow id=d9430e1997 href="http://www.ncbi.nlm.nih.gov/pubmed/18574618">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2000 href="https://doi.org/10.1007/s00415-008-0872-0">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d9430e2009 class=n-a></a>Dyck PJ, Norell JE, Tritschler H, <i> et al.</i>: Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. <i>Diabetes Care.</i> 2007; <b>30</b>(10): 2619–25. <a target=xrefwindow id=d9430e2020 href="http://www.ncbi.nlm.nih.gov/pubmed/17513707">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2023 href="https://doi.org/10.2337/dc06-2479">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d9430e2032 class=n-a></a>Malik RA: Which test for diagnosing early human diabetic neuropathy? <i>Diabetes.</i> 2014; <b>63</b>(7): 2206–8. <a target=xrefwindow id=d9430e2040 href="http://www.ncbi.nlm.nih.gov/pubmed/24962918">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2043 href="https://doi.org/10.2337/db14-0492">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d9430e2053 class=n-a></a>Apfel SC: Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? <i>Int Rev Neurobiol.</i> 2002; <b>50</b>: 393–413. <a target=xrefwindow id=d9430e2061 href="http://www.ncbi.nlm.nih.gov/pubmed/12198818">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2064 href="https://doi.org/10.1016/S0074-7742(02)50083-0">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d9430e2073 class=n-a></a>Kennedy WR, Navarro X, Goetz FC, <i> et al.</i>: Effects of pancreatic transplantation on diabetic neuropathy. <i>N Engl J Med.</i> 1990; <b>322</b>(15): 1031–7. <a target=xrefwindow id=d9430e2084 href="http://www.ncbi.nlm.nih.gov/pubmed/2320063">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2087 href="https://doi.org/10.1056/NEJM199004123221503">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726151906"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2096 class=n-a></a>Wahren J, Foyt H, Daniels M, <i> et al.</i>: Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial. <i>Diabetes Care.</i> 2016; <b>39</b>(4): 596–602. <a target=xrefwindow id=d9430e2107 href="http://www.ncbi.nlm.nih.gov/pubmed/26884473">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2110 href="https://doi.org/10.2337/dc15-2068">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726151906">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1165688"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2123 class=n-a></a>Bakkers M, Merkies IS, Lauria G, <i> et al.</i>: Intraepidermal nerve fiber density and its application in sarcoidosis. <i>Neurology.</i> 2009; <b>73</b>(14): 1142–8. <a target=xrefwindow id=d9430e2134 href="http://www.ncbi.nlm.nih.gov/pubmed/19805731">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2137 href="https://doi.org/10.1212/WNL.0b013e3181bacf05">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1165688">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d9430e2150 class=n-a></a>Asghar O, Petropoulos IN, Alam U, <i> et al.</i>: Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. <i>Diabetes Care.</i> 2014; <b>37</b>(9): 2643–6. <a target=xrefwindow id=d9430e2161 href="http://www.ncbi.nlm.nih.gov/pubmed/24969581">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2164 href="https://doi.org/10.2337/dc14-0279">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2168 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4140158">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726998685"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2177 class=n-a></a>Løseth S, Stålberg EV, Lindal S, <i> et al.</i>: Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study. <i>J Peripher Nerv Syst.</i> 2016; <b>21</b>(1): 15–21. <a target=xrefwindow id=d9430e2188 href="http://www.ncbi.nlm.nih.gov/pubmed/26663481">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2191 href="https://doi.org/10.1111/jns.12154">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726998685">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/30662"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2205 class=n-a></a>Smith AG, Russell J, Feldman EL, <i> et al.</i>: Lifestyle intervention for pre-diabetic neuropathy. <i>Diabetes Care.</i> 2006; <b>29</b>(6): 1294–9. <a target=xrefwindow id=d9430e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/16732011">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2219 href="https://doi.org/10.2337/dc06-0224">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/30662">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d9430e2232 class=n-a></a>Lauria G, Cornblath DR, Johansson O, <i> et al.</i>: EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. <i>Eur J Neurol.</i> 2005; <b>12</b>(10): 747–58. <a target=xrefwindow id=d9430e2243 href="http://www.ncbi.nlm.nih.gov/pubmed/16190912">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2246 href="https://doi.org/10.1111/j.1468-1331.2005.01260.x">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d9430e2255 class=n-a></a>Malik RA, Kallinikos P, Abbott CA, <i> et al.</i>: Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. <i>Diabetologia.</i> 2003; <b>46</b>(5): 683–8. <a target=xrefwindow id=d9430e2266 href="http://www.ncbi.nlm.nih.gov/pubmed/12739016">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2269 href="https://doi.org/10.1007/s00125-003-1086-8">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d9430e2278 class=n-a></a>Hertz P, Bril V, Orszag A, <i> et al.</i>: Reproducibility of <i>in vivo</i> corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. <i>Diabet Med.</i> 2011; <b>28</b>(10): 1253–60. <a target=xrefwindow id=d9430e2292 href="http://www.ncbi.nlm.nih.gov/pubmed/21434993">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2296 href="https://doi.org/10.1111/j.1464-5491.2011.03299.x">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d9430e2305 class=n-a></a>Kawashima W, Hatake K, Kudo R, <i> et al.</i>: Estimating the Time after Death on the Basis of Corneal Opacity. <i>J Forensic Res.</i> 2014; <b>6</b>: 269. <a target=xrefwindow id=d9430e2316 href="https://doi.org/10.4172/2157-7145.1000269">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d9430e2325 class=n-a></a>Perkins BA, Lovblom LE, Bril V, <i> et al.</i>: Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. <i>Diabetologia.</i> 2018; <b>61</b>(8): 1856–61. <a target=xrefwindow id=d9430e2336 href="http://www.ncbi.nlm.nih.gov/pubmed/29869146">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2339 href="https://doi.org/10.1007/s00125-018-4653-8">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2343 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6061173">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d9430e2353 class=n-a></a>Petropoulos IN, Alam U, Fadavi H, <i> et al.</i>: Rapid automated diagnosis of diabetic peripheral neuropathy with <i>in vivo</i> corneal confocal microscopy. <i>Invest Ophthalmol Vis Sci.</i> 2014; <b>55</b>(4): 2071–8. <a target=xrefwindow id=d9430e2367 href="http://www.ncbi.nlm.nih.gov/pubmed/24569580">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2371 href="https://doi.org/10.1167/iovs.13-13787">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2374 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3979234">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d9430e2383 class=n-a></a>Pritchard N, Edwards K, Dehghani C, <i> et al.</i>: Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): study design and baseline characteristics. <i>Diabetes Res Clin Pract.</i> 2014; <b>104</b>(2): 248–56. <a target=xrefwindow id=d9430e2394 href="http://www.ncbi.nlm.nih.gov/pubmed/24629408">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2397 href="https://doi.org/10.1016/j.diabres.2014.02.011">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d9430e2406 class=n-a></a>Azmi S, Ferdousi M, Petropoulos IN, <i> et al.</i>: Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes. <i>Diabetes Care.</i> 2015; <b>38</b>(8): 1502–8. <a target=xrefwindow id=d9430e2417 href="http://www.ncbi.nlm.nih.gov/pubmed/25877814">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2420 href="https://doi.org/10.2337/dc14-2733">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2424 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4512140">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d9430e2433 class=n-a></a>Pritchard N, Edwards K, Russell AW, <i> et al.</i>: Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes. <i>Diabetes Care.</i> 2015; <b>38</b>(4): 671–5. <a target=xrefwindow id=d9430e2444 href="http://www.ncbi.nlm.nih.gov/pubmed/25573881">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2447 href="https://doi.org/10.2337/dc14-2114">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d9430e2456 class=n-a></a>Tavakoli M, Mitu-Pretorian M, Petropoulos IN, <i> et al.</i>: Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. <i>Diabetes.</i> 2013; <b>62</b>(1): 254–60. <a target=xrefwindow id=d9430e2467 href="http://www.ncbi.nlm.nih.gov/pubmed/23002037">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2470 href="https://doi.org/10.2337/db12-0574">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2474 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3526062">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d9430e2483 class=n-a></a>Azmi S, Ferdousi M, Petropoulos IN, <i> et al.</i>: Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection. <i>Diabetes Care.</i> 2015; <b>38</b>(1): e3–4. <a target=xrefwindow id=d9430e2494 href="http://www.ncbi.nlm.nih.gov/pubmed/25538321">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2497 href="https://doi.org/10.2337/dc14-1698">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d9430e2507 class=n-a></a>Culver DA, Dahan A, Bajorunas D, <i> et al.</i>: Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. <i>Invest Ophthalmol Vis Sci.</i> 2017; <b>58</b>(6): BIO52–BIO60. <a target=xrefwindow id=d9430e2518 href="http://www.ncbi.nlm.nih.gov/pubmed/28475703">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2521 href="https://doi.org/10.1167/iovs.16-21291">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d9430e2530 class=n-a></a>Lewis EJH, Perkins BA, Lovblom LE, <i> et al.</i>: Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial. <i>Neurology.</i> 2017; <b>88</b>(24): 2294–301. <a target=xrefwindow id=d9430e2541 href="http://www.ncbi.nlm.nih.gov/pubmed/28515269">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2544 href="https://doi.org/10.1212/WNL.0000000000004033">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2548 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5567321">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d9430e2557 class=n-a></a>Lee CC, Perkins BA, Kayaniyil S, <i> et al.</i>: Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort. <i>Diabetes Care.</i> 2015; <b>38</b>(5): 793–800. <a target=xrefwindow id=d9430e2568 href="http://www.ncbi.nlm.nih.gov/pubmed/25665810">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2571 href="https://doi.org/10.2337/dc14-2585">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d9430e2580 class=n-a></a>Ferdousi M, Azmi S, Petropoulos IN, <i> et al.</i>: Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy. <i>PLoS One.</i> 2015; <b>10</b>(10): e0139394. <a target=xrefwindow id=d9430e2591 href="http://www.ncbi.nlm.nih.gov/pubmed/26430773">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2594 href="https://doi.org/10.1371/journal.pone.0139394">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2598 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4592260">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d9430e2607 class=n-a></a>Ang L, Jaiswal M, Martin C, <i> et al.</i>: Glucose control and diabetic neuropathy: lessons from recent large clinical trials. <i>Curr Diab Rep.</i> 2014; <b>14</b>(9): 528. <a target=xrefwindow id=d9430e2618 href="http://www.ncbi.nlm.nih.gov/pubmed/25139473">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2621 href="https://doi.org/10.1007/s11892-014-0528-7">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2625 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5084623">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d9430e2634 class=n-a></a>Ohkubo Y, Kishikawa H, Araki E, <i> et al.</i>: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. <i>Diabetes Res Clin Pract.</i> 1995; <b>28</b>(2): 103–17. <a target=xrefwindow id=d9430e2645 href="http://www.ncbi.nlm.nih.gov/pubmed/7587918">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2648 href="https://doi.org/10.1016/0168-8227(95)01064-K">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4851957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2658 class=n-a></a>Ismail-Beigi F, Craven T, Banerji MA, <i> et al.</i>: Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. <i>Lancet.</i> 2010; <b>376</b>(9739): 419–30. <a target=xrefwindow id=d9430e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/20594588">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2672 href="https://doi.org/10.1016/S0140-6736(10)60576-4">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2676 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4123233">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4851957">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d9430e2689 class=n-a></a>Callaghan BC, Little AA, Feldman EL, <i> et al.</i>: Enhanced glucose control for preventing and treating diabetic neuropathy. <i>Cochrane Database Syst Rev.</i> 2012; (6): CD007543. <a target=xrefwindow id=d9430e2697 href="http://www.ncbi.nlm.nih.gov/pubmed/22696371">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2700 href="https://doi.org/10.1002/14651858.CD007543.pub2">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2703 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4048127">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d9430e2712 class=n-a></a>Tesfaye S, Chaturvedi N, Eaton SE, <i> et al.</i>: Vascular risk factors and diabetic neuropathy. <i>N Engl J Med.</i> 2005; <b>352</b>(4): 341–50. <a target=xrefwindow id=d9430e2723 href="http://www.ncbi.nlm.nih.gov/pubmed/15673800">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2726 href="https://doi.org/10.1056/NEJMoa032782">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d9430e2735 class=n-a></a>Malik RA, Williamson S, Abbott C, <i> et al.</i>: Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. <i>Lancet.</i> 1998; <b>352</b>(9145): 1978–81. <a target=xrefwindow id=d9430e2746 href="http://www.ncbi.nlm.nih.gov/pubmed/9872248">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2749 href="https://doi.org/10.1016/S0140-6736(98)02478-7">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d9430e2758 class=n-a></a>Ruggenenti P, Lauria G, Iliev IP, <i> et al.</i>: Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. <i>Hypertension.</i> 2011; <b>58</b>(5): 776–83. <a target=xrefwindow id=d9430e2769 href="http://www.ncbi.nlm.nih.gov/pubmed/21931073">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2772 href="https://doi.org/10.1161/HYPERTENSIONAHA.111.174474">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d9430e2781 class=n-a></a>Malik RA: Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors? <i>Ann Med.</i> 2000; <b>32</b>(1): 1–5. <a target=xrefwindow id=d9430e2789 href="http://www.ncbi.nlm.nih.gov/pubmed/10711571">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2792 href="https://doi.org/10.3109/07853890008995903">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d9430e2802 class=n-a></a>Malik RA, Tomlinson DR: Angiotensin-converting enzyme inhibitors: are there credible mechanisms for beneficial effects in diabetic neuropathy? <i>Int Rev Neurobiol.</i> 2002; <b>50</b>: 415–30. <a target=xrefwindow id=d9430e2810 href="http://www.ncbi.nlm.nih.gov/pubmed/12198819">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2813 href="https://doi.org/10.1016/S0074-7742(02)50084-2">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725225788"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2822 class=n-a></a>Nielsen SF, Nordestgaard BG: Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study. <i>Lancet Diabetes Endocrinol.</i> 2014; <b>2</b>(11): 894–900. <a target=xrefwindow id=d9430e2830 href="http://www.ncbi.nlm.nih.gov/pubmed/25217178">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2833 href="https://doi.org/10.1016/S2213-8587(14)70173-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725225788">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1105231"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2846 class=n-a></a>Davis TM, Yeap BB, Davis WA, <i> et al.</i>: Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study. <i>Diabetologia.</i> 2008; <b>51</b>(4): 562–6. <a target=xrefwindow id=d9430e2857 href="http://www.ncbi.nlm.nih.gov/pubmed/18193189">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2860 href="https://doi.org/10.1007/s00125-007-0919-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1105231">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d9430e2873 class=n-a></a>Nassaji M, Ghorbani R, Saboori Shkofte H: Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study. <i>Wounds.</i> 2017; <b>29</b>(7): 196–201. <a target=xrefwindow id=d9430e2881 href="http://www.ncbi.nlm.nih.gov/pubmed/28762948">PubMed Abstract </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d9430e2890 class=n-a></a>Rajamani K, Colman PG, Li LP, <i> et al.</i>: Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. <i>Lancet.</i> 2009; <b>373</b>(9677): 1780–8. <a target=xrefwindow id=d9430e2901 href="http://www.ncbi.nlm.nih.gov/pubmed/19465233">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2904 href="https://doi.org/10.1016/S0140-6736(09)60698-X">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2908 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2687887">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d9430e2917 class=n-a></a>Sohn MW, Meadows JL, Oh EH, <i> et al.</i>: Statin use and lower extremity amputation risk in nonelderly diabetic patients. <i>J Vasc Surg.</i> 2013; <b>58</b>(6): 1578–1585.e1. <a target=xrefwindow id=d9430e2928 href="http://www.ncbi.nlm.nih.gov/pubmed/23932803">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2931 href="https://doi.org/10.1016/j.jvs.2013.06.069">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3844128">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735007966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2945 class=n-a></a>Fox JD, Baquerizo-Nole KL, Macquhae F, <i> et al.</i>: Statins may be associated with six-week diabetic foot ulcer healing. <i>Wound Repair Regen.</i> 2016; <b>24</b>(2): 454–7. <a target=xrefwindow id=d9430e2956 href="http://www.ncbi.nlm.nih.gov/pubmed/26748844">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2959 href="https://doi.org/10.1111/wrr.12400">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735007966">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733760706"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e2972 class=n-a></a>Davidson EP, Coppey LJ, Shevalye H, <i> et al.</i>: Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats. <i>J Diabetes Res.</i> 2018; <b>2018</b>: 2967127. <a target=xrefwindow id=d9430e2983 href="http://www.ncbi.nlm.nih.gov/pubmed/30057911">PubMed Abstract </a> | <a target=xrefwindow id=d9430e2986 href="https://doi.org/10.1155/2018/2967127">Publisher Full Text </a> | <a target=xrefwindow id=d9430e2990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6051246">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733760706">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727676485"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3003 class=n-a></a>Davidson EP, Coppey LJ, Shevalye H, <i> et al.</i>: Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril. <i>Cornea.</i> 2017; <b>36</b>(6): 725–31. <a target=xrefwindow id=d9430e3014 href="http://www.ncbi.nlm.nih.gov/pubmed/28476051">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3017 href="https://doi.org/10.1097/ICO.0000000000001182">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3021 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5421399">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727676485">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733512747"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3034 class=n-a></a>Davidson EP, Coppey LJ, Shevalye H, <i> et al.</i>: Vascular and Neural Complications in Type 2 Diabetic Rats: Improvement by Sacubitril/Valsartan Greater Than Valsartan Alone. <i>Diabetes.</i> 2018; <b>67</b>(8): 1616–26. <a target=xrefwindow id=d9430e3045 href="http://www.ncbi.nlm.nih.gov/pubmed/29941448">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3048 href="https://doi.org/10.2337/db18-0062">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733512747">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d9430e3061 class=n-a></a>Sorensen L, Molyneaux L, Yue DK: The relationship among pain, sensory loss, and small nerve fibers in diabetes. <i>Diabetes Care.</i> 2006; <b>29</b>(4): 883–7. <a target=xrefwindow id=d9430e3069 href="http://www.ncbi.nlm.nih.gov/pubmed/16567832">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3072 href="https://doi.org/10.2337/diacare.29.04.06.dc05-2180">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d9430e3081 class=n-a></a>Vlckova-Moravcova E, Bednarik J, Belobradkova J, <i> et al.</i>: Small-fibre involvement in diabetic patients with neuropathic foot pain. <i>Diabet Med.</i> 2008; <b>25</b>(6): 692–9. <a target=xrefwindow id=d9430e3092 href="http://www.ncbi.nlm.nih.gov/pubmed/18544107">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3095 href="https://doi.org/10.1111/j.1464-5491.2008.02446.x">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d9430e3105 class=n-a></a>Quattrini C, Tavakoli M, Jeziorska M, <i> et al.</i>: Surrogate markers of small fiber damage in human diabetic neuropathy. <i>Diabetes.</i> 2007; <b>56</b>(8): 2148–54. <a target=xrefwindow id=d9430e3116 href="http://www.ncbi.nlm.nih.gov/pubmed/17513704">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3119 href="https://doi.org/10.2337/db07-0285">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d9430e3128 class=n-a></a>van Acker K, Bouhassira D, de Bacquer D, <i> et al.</i>: Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. <i>Diabetes Metab.</i> 2009; <b>35</b>(3): 206–13. <a target=xrefwindow id=d9430e3139 href="http://www.ncbi.nlm.nih.gov/pubmed/19297223">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3142 href="https://doi.org/10.1016/j.diabet.2008.11.004">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d9430e3151 class=n-a></a>Bohlega S, Alsaadi T, Amir A, <i> et al.</i>: Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region. <i>J Int Med Res.</i> 2010; <b>38</b>(2): 295–317. <a target=xrefwindow id=d9430e3162 href="http://www.ncbi.nlm.nih.gov/pubmed/20515552">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3165 href="https://doi.org/10.1177/147323001003800201">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d9430e3174 class=n-a></a>daCosta DiBonaventura M, Cappelleri JC, Joshi AV: A longitudinal assessment of painful diabetic peripheral neuropathy on health status, productivity, and health care utilization and cost. <i>Pain Med.</i> 2011; <b>12</b>(1): 118–26. <a target=xrefwindow id=d9430e3182 href="http://www.ncbi.nlm.nih.gov/pubmed/21087406">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3185 href="https://doi.org/10.1111/j.1526-4637.2010.01012.x">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d9430e3194 class=n-a></a>Abbott CA, Malik RA, van Ross ER, <i> et al.</i>: Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. <i>Diabetes Care.</i> 2011; <b>34</b>(10): 2220–4. <a target=xrefwindow id=d9430e3205 href="http://www.ncbi.nlm.nih.gov/pubmed/21852677">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3208 href="https://doi.org/10.2337/dc11-1108">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3212 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3177727">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d9430e3221 class=n-a></a>Jambart S, Ammache Z, Haddad F, <i> et al.</i>: Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. <i>J Int Med Res.</i> 2011; <b>39</b>(2): 366–77. <a target=xrefwindow id=d9430e3232 href="http://www.ncbi.nlm.nih.gov/pubmed/21672340">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3235 href="https://doi.org/10.1177/147323001103900204">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d9430e3245 class=n-a></a>Davies M, Brophy S, Williams R, <i> et al.</i>: The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. <i>Diabetes Care.</i> 2006; <b>29</b>(7): 1518–22. <a target=xrefwindow id=d9430e3256 href="http://www.ncbi.nlm.nih.gov/pubmed/16801572">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3259 href="https://doi.org/10.2337/dc05-2228">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d9430e3268 class=n-a></a>Ziegler D, Rathmann W, Meisinger C, <i> et al.</i>: Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry. <i>Eur J Pain.</i> 2009; <b>13</b>(6): 582–7. <a target=xrefwindow id=d9430e3279 href="http://www.ncbi.nlm.nih.gov/pubmed/18782673">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3282 href="https://doi.org/10.1016/j.ejpain.2008.07.007">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d9430e3291 class=n-a></a>Jacovides A, Bogoshi M, Distiller LA, <i> et al.</i>: An epidemiological study to assess the prevalence of diabetic peripheral neuropathic pain among adults with diabetes attending private and institutional outpatient clinics in South Africa. <i>J Int Med Res.</i> 2014; <b>42</b>(4): 1018–28. <a target=xrefwindow id=d9430e3302 href="http://www.ncbi.nlm.nih.gov/pubmed/24891556">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3305 href="https://doi.org/10.1177/0300060514525759">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d9430e3314 class=n-a></a>Sadosky A, McDermott AM, Brandenburg NA, <i> et al.</i>: A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. <i>Pain Pract.</i> 2008; <b>8</b>(1): 45–56. <a target=xrefwindow id=d9430e3325 href="http://www.ncbi.nlm.nih.gov/pubmed/18211592">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3328 href="https://doi.org/10.1111/j.1533-2500.2007.00164.x">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d9430e3337 class=n-a></a>Aslam A, Singh J, Rajbhandari S: Prevalence of Painful Diabetic Neuropathy Using the Self-Completed Leeds Assessment of Neuropathic Symptoms and Signs Questionnaire in a Population with Diabetes. <i>Can J Diabetes.</i> 2015; <b>39</b>(4): 285–95. <a target=xrefwindow id=d9430e3345 href="http://www.ncbi.nlm.nih.gov/pubmed/25935401">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3348 href="https://doi.org/10.1016/j.jcjd.2014.12.007">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732818188"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3357 class=n-a></a>Ziegler D, Landgraf R, Lobmann R, <i> et al.</i>: Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). <i>Diabetes Res Clin Pract.</i> 2018; <b>139</b>: 147–54. <a target=xrefwindow id=d9430e3368 href="http://www.ncbi.nlm.nih.gov/pubmed/29518491">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3371 href="https://doi.org/10.1016/j.diabres.2018.02.043">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732818188">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d9430e3385 class=n-a></a>Daousi C, MacFarlane IA, Woodward A, <i> et al.</i>: Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. <i>Diabet Med.</i> 2004; <b>21</b>(9): 976–82. <a target=xrefwindow id=d9430e3396 href="http://www.ncbi.nlm.nih.gov/pubmed/15317601">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3399 href="https://doi.org/10.1111/j.1464-5491.2004.01271.x">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d9430e3408 class=n-a></a>Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. <i>Diabetes Care.</i> 1993; <b>16</b>(11): 1446–52. <a target=xrefwindow id=d9430e3416 href="http://www.ncbi.nlm.nih.gov/pubmed/8299433">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3419 href="https://doi.org/10.2337/diacare.16.11.1446">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d9430e3428 class=n-a></a>Smith AG, Singleton JR: Impaired glucose tolerance and neuropathy. <i>Neurologist.</i> 2008; <b>14</b>(1): 23–9. <a target=xrefwindow id=d9430e3436 href="http://www.ncbi.nlm.nih.gov/pubmed/18195653">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3439 href="https://doi.org/10.1097/NRL.0b013e31815a3956">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d9430e3448 class=n-a></a>Spallone V, Morganti R, D'Amato C, <i> et al.</i>: Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. <i>Diabet Med.</i> 2012; <b>29</b>(5): 578–85. <a target=xrefwindow id=d9430e3459 href="http://www.ncbi.nlm.nih.gov/pubmed/22023377">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3462 href="https://doi.org/10.1111/j.1464-5491.2011.03500.x">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d9430e3471 class=n-a></a>Bennett M: The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. <i>Pain.</i> 2001; <b>92</b>(1–2): 147–57. <a target=xrefwindow id=d9430e3479 href="http://www.ncbi.nlm.nih.gov/pubmed/11323136">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3482 href="https://doi.org/10.1016/S0304-3959(00)00482-6">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d9430e3491 class=n-a></a>Krause SJ, Backonja MM: Development of a neuropathic pain questionnaire. <i>Clin J Pain.</i> 2003; <b>19</b>(5): 306–14. <a target=xrefwindow id=d9430e3499 href="http://www.ncbi.nlm.nih.gov/pubmed/12966256">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3502 href="https://doi.org/10.1097/00002508-200309000-00004">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d9430e3512 class=n-a></a>Unal-Cevik I, Sarioglu-Ay S, Evcik D: A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. <i>J Pain.</i> 2010; <b>11</b>(11): 1129–35. <a target=xrefwindow id=d9430e3520 href="http://www.ncbi.nlm.nih.gov/pubmed/20418179">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3523 href="https://doi.org/10.1016/j.jpain.2010.02.003">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725235038"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3532 class=n-a></a>Gibbons CH, Freeman R: Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. <i>Brain.</i> 2015; <b>138</b>(Pt 1): 43–52. <a target=xrefwindow id=d9430e3540 href="http://www.ncbi.nlm.nih.gov/pubmed/25392197">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3543 href="https://doi.org/10.1093/brain/awu307">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3546 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4285188">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725235038">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727695647"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3559 class=n-a></a>Vollert J, Maier C, Attal N, <i> et al.</i>: Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations. <i>Pain.</i> 2017; <b>158</b>(8): 1446–55. <a target=xrefwindow id=d9430e3570 href="http://www.ncbi.nlm.nih.gov/pubmed/28595241">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3573 href="https://doi.org/10.1097/j.pain.0000000000000935">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5515640">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727695647">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d9430e3590 class=n-a></a>Demant DT, Lund K, Vollert J, <i> et al.</i>: The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. <i>Pain.</i> 2014; <b>155</b>(11): 2263–73. <a target=xrefwindow id=d9430e3601 href="http://www.ncbi.nlm.nih.gov/pubmed/25139589">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3604 href="https://doi.org/10.1016/j.pain.2014.08.014">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d9430e3613 class=n-a></a>Marshall AG, Lee-Kubli C, Azmi S, <i> et al.</i>: Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy. <i>Diabetes.</i> 2017; <b>66</b>(5): 1380–90. <a target=xrefwindow id=d9430e3624 href="http://www.ncbi.nlm.nih.gov/pubmed/28202580">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3627 href="https://doi.org/10.2337/db16-1181">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3631 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5399611">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d9430e3640 class=n-a></a>Botney M, Fields HL: Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. <i>Ann Neurol.</i> 1983; <b>13</b>(2): 160–4. <a target=xrefwindow id=d9430e3648 href="http://www.ncbi.nlm.nih.gov/pubmed/6219612">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3651 href="https://doi.org/10.1002/ana.410130209">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d9430e3661 class=n-a></a>Benbouzid M, Gavériaux-Ruff C, Yalcin I, <i> et al.</i>: Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. <i>Biol Psychiatry.</i> 2008; <b>63</b>(6): 633–6. <a target=xrefwindow id=d9430e3672 href="http://www.ncbi.nlm.nih.gov/pubmed/17693391">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3675 href="https://doi.org/10.1016/j.biopsych.2007.06.016">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d9430e3684 class=n-a></a>de Gandarias JM, Echevarria E, Acebes I, <i> et al.</i>: Effects of imipramine administration on mu-opioid receptor immunostaining in the rat forebrain. <i>Arzneimittelforschung.</i> 1998; <b>48</b>(7): 717–9. <a target=xrefwindow id=d9430e3695 href="http://www.ncbi.nlm.nih.gov/pubmed/9706370">PubMed Abstract </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725618159"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3704 class=n-a></a>Moore RA, Derry S, Aldington D, <i> et al.</i>: Amitriptyline for neuropathic pain in adults. <i>Cochrane Database Syst Rev.</i> 2015; (7): CD008242. <a target=xrefwindow id=d9430e3712 href="http://www.ncbi.nlm.nih.gov/pubmed/26146793">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3715 href="https://doi.org/10.1002/14651858.CD008242.pub3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725618159">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726042755"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3728 class=n-a></a>Hossain SM, Hussain SM, Ekram AR: Duloxetine in Painful Diabetic Neuropathy: A Systematic Review. <i>Clin J Pain.</i> 2016; <b>32</b>(11): 1005–10. <a target=xrefwindow id=d9430e3736 href="http://www.ncbi.nlm.nih.gov/pubmed/26710221">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3739 href="https://doi.org/10.1097/AJP.0000000000000343">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726042755">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d9430e3752 class=n-a></a>Lunn MP, Hughes RA, Wiffen PJ: Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. <i>Cochrane Database Syst Rev.</i> 2014; (1): CD007115. <a target=xrefwindow id=d9430e3757 href="http://www.ncbi.nlm.nih.gov/pubmed/24385423">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3760 href="https://doi.org/10.1002/14651858.CD007115.pub3">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d9430e3769 class=n-a></a>Lesser H, Sharma U, LaMoreaux L, <i> et al.</i>: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. <i>Neurology.</i> 2004; <b>63</b>(11): 2104–10. <a target=xrefwindow id=d9430e3780 href="http://www.ncbi.nlm.nih.gov/pubmed/15596757">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3783 href="https://doi.org/10.1212/01.WNL.0000145767.36287.A1">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d9430e3793 class=n-a></a>Rosenstock J, Tuchman M, LaMoreaux L, <i> et al.</i>: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. <i>Pain.</i> 2004; <b>110</b>(3): 628–38. <a target=xrefwindow id=d9430e3804 href="http://www.ncbi.nlm.nih.gov/pubmed/15288403">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3807 href="https://doi.org/10.1016/j.pain.2004.05.001">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d9430e3816 class=n-a></a>Arezzo JC, Rosenstock J, LaMoreaux L, <i> et al.</i>: Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. <i>BMC Neurol.</i> 2008; <b>8</b>: 33. <a target=xrefwindow id=d9430e3827 href="http://www.ncbi.nlm.nih.gov/pubmed/18796160">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3830 href="https://doi.org/10.1186/1471-2377-8-33">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3834 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2565674">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d9430e3843 class=n-a></a>Snedecor SJ, Sudharshan L, Cappelleri JC, <i> et al.</i>: Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. <i>Pain Pract.</i> 2014; <b>14</b>(2): 167–84. <a target=xrefwindow id=d9430e3854 href="http://www.ncbi.nlm.nih.gov/pubmed/23534696">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3857 href="https://doi.org/10.1111/papr.12054">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d9430e3866 class=n-a></a>Iqbal Z, Azmi S, Yadav R, <i> et al.</i>: Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. <i>Clin Ther.</i> 2018; <b>40</b>(6): 828–49. <a target=xrefwindow id=d9430e3877 href="http://www.ncbi.nlm.nih.gov/pubmed/29709457">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3880 href="https://doi.org/10.1016/j.clinthera.2018.04.001">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d9430e3889 class=n-a></a>Javed S, Alam U, Malik RA: Mirogabalin and emerging therapies for diabetic neuropathy. <i>J Pain Res.</i> 2018; <b>11</b>: 1559–66. <a target=xrefwindow id=d9430e3897 href="http://www.ncbi.nlm.nih.gov/pubmed/30174455">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3900 href="https://doi.org/10.2147/JPR.S145999">Publisher Full Text </a> | <a target=xrefwindow id=d9430e3903 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6110292">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727472447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3912 class=n-a></a>Merante D, Rosenstock J, Sharma U, <i> et al.</i>: Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study. <i>Pain Med.</i> 2017; <b>18</b>(11): 2198–207. <a target=xrefwindow id=d9430e3923 href="http://www.ncbi.nlm.nih.gov/pubmed/28371941">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3926 href="https://doi.org/10.1093/pm/pnw342">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727472447">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d9430e3940 class=n-a></a>Vinik A, Rosenstock J, Sharma U, <i> et al.</i>: Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. <i>Diabetes Care.</i> 2014; <b>37</b>(12): 3253–61. <a target=xrefwindow id=d9430e3951 href="http://www.ncbi.nlm.nih.gov/pubmed/25231896">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3954 href="https://doi.org/10.2337/dc14-1044">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727719790"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e3963 class=n-a></a>Duehmke RM, Derry S, Wiffen PJ, <i> et al.</i>: Tramadol for neuropathic pain in adults. <i>Cochrane Database Syst Rev.</i> 2017; <b>6</b>: CD003726. <a target=xrefwindow id=d9430e3974 href="http://www.ncbi.nlm.nih.gov/pubmed/28616956">PubMed Abstract </a> | <a target=xrefwindow id=d9430e3977 href="https://doi.org/10.1002/14651858.CD003726.pub4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727719790">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d9430e3990 class=n-a></a>Vinik AI, Shapiro DY, Rauschkolb C, <i> et al.</i>: A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy. <i>Diabetes Care.</i> 2014; <b>37</b>(8): 2302–9. <a target=xrefwindow id=d9430e4001 href="http://www.ncbi.nlm.nih.gov/pubmed/24848284">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4004 href="https://doi.org/10.2337/dc13-2291">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718344110"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4013 class=n-a></a>Niesters M, Proto PL, Aarts L, <i> et al.</i>: Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. <i>Br J Anaesth.</i> 2014; <b>113</b>(1): 148–56. <a target=xrefwindow id=d9430e4024 href="http://www.ncbi.nlm.nih.gov/pubmed/24713310">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4027 href="https://doi.org/10.1093/bja/aeu056">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718344110">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d9430e4040 class=n-a></a>Schwartz S, Etropolski MS, Shapiro DY, <i> et al.</i>: A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy. <i>Clin Drug Investig.</i> 2015; <b>35</b>(2): 95–108. <a target=xrefwindow id=d9430e4051 href="http://www.ncbi.nlm.nih.gov/pubmed/25503082">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4054 href="https://doi.org/10.1007/s40261-014-0249-3">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4058 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4300409">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d9430e4067 class=n-a></a>Vadivelu N, Kai A, Maslin B, <i> et al.</i>: Tapentadol extended release in the management of peripheral diabetic neuropathic pain. <i>Ther Clin Risk Manag.</i> 2015; <b>11</b>: 95–105. <a target=xrefwindow id=d9430e4078 href="http://www.ncbi.nlm.nih.gov/pubmed/25609974">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4081 href="https://doi.org/10.2147/TCRM.S32193">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4085 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4298300">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718016851"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4095 class=n-a></a>Tesfaye S, Wilhelm S, Lledo A, <i> et al.</i>: Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. <i>Pain.</i> 2013; <b>154</b>(12): 2616–25. <a target=xrefwindow id=d9430e4106 href="http://www.ncbi.nlm.nih.gov/pubmed/23732189">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4109 href="https://doi.org/10.1016/j.pain.2013.05.043">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718016851">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d9430e4122 class=n-a></a>Bouhassira D, Wilhelm S, Schacht A, <i> et al.</i>: Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study. <i>Pain.</i> 2014; <b>155</b>(10): 2171–9. <a target=xrefwindow id=d9430e4133 href="http://www.ncbi.nlm.nih.gov/pubmed/25168665">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4136 href="https://doi.org/10.1016/j.pain.2014.08.020">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717958639"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4145 class=n-a></a>Boyle J, Eriksson ME, Gribble L, <i> et al.</i>: Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. <i>Diabetes Care.</i> 2012; <b>35</b>(12): 2451–8. <a target=xrefwindow id=d9430e4156 href="http://www.ncbi.nlm.nih.gov/pubmed/22991449">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4159 href="https://doi.org/10.2337/dc12-0656">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4163 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3507552">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717958639">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d9430e4176 class=n-a></a>Yuen KC, Baker NR, Rayman G: Treatment of Chronic Painful Diabetic Neuropathy With Isosorbide Dinitrate Spray: a double-blind placebo-controlled cross-over study. <i>Diabetes Care.</i> 2002; <b>25</b>(10): 1699–703. <a target=xrefwindow id=d9430e4184 href="http://www.ncbi.nlm.nih.gov/pubmed/12351464">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4187 href="https://doi.org/10.2337/diacare.25.10.1699">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d9430e4196 class=n-a></a>Rayman G, Baker NR, Krishnan ST: Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. <i>Diabetes Care.</i> 2003; <b>26</b>(9): 2697–8. <a target=xrefwindow id=d9430e4204 href="http://www.ncbi.nlm.nih.gov/pubmed/12941745">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4207 href="https://doi.org/10.2337/diacare.26.9.2697-a">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d9430e4216 class=n-a></a>Agrawal RP, Choudhary R, Sharma P, <i> et al.</i>: Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. <i>Diabetes Res Clin Pract.</i> 2007; <b>77</b>(2): 161–7. <a target=xrefwindow id=d9430e4227 href="http://www.ncbi.nlm.nih.gov/pubmed/17316865">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4230 href="https://doi.org/10.1016/j.diabres.2006.12.003">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d9430e4240 class=n-a></a>Agrawal RP, Goswami J, Jain S, <i> et al.</i>: Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. <i>Diabetes Res Clin Pract.</i> 2009; <b>83</b>(3): 371–8. <a target=xrefwindow id=d9430e4251 href="http://www.ncbi.nlm.nih.gov/pubmed/19208440">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4254 href="https://doi.org/10.1016/j.diabres.2008.12.018">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d9430e4263 class=n-a></a>Alam U, Jeziorska M, Petropoulos IN, <i> et al.</i>: Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. <i>PLoS One.</i> 2017; <b>12</b>(7): e0180175. <a target=xrefwindow id=d9430e4274 href="http://www.ncbi.nlm.nih.gov/pubmed/28719619">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4277 href="https://doi.org/10.1371/journal.pone.0180175">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4281 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5515394">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d9430e4290 class=n-a></a>Kalteniece A, Ferdousi M, Petropoulos I, <i> et al.</i>: Greater corneal nerve loss at the inferior whorl is related to the presence of diabetic neuropathy and painful diabetic neuropathy. <i>Sci Rep.</i> 2018; <b>8</b>(1): 3283. <a target=xrefwindow id=d9430e4301 href="http://www.ncbi.nlm.nih.gov/pubmed/29459766">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4304 href="https://doi.org/10.1038/s41598-018-21643-z">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4308 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5818543">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734643914"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4317 class=n-a></a>Eijkenboom I, Sopacua M, Hoeijmakers JGJ, <i> et al.</i>: Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. <i>J Neurol Neurosurg Psychiatr.</i> 2018; pii: jnnp-2018-319042. <a target=xrefwindow id=d9430e4325 href="http://www.ncbi.nlm.nih.gov/pubmed/30554136">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4328 href="https://doi.org/10.1136/jnnp-2018-319042">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734643914">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d9430e4341 class=n-a></a>Huang J, Han C, Estacion M, <i> et al.</i>: Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy. <i>Brain.</i> 2014; <b>137</b>(Pt 6): 1627–42. <a target=xrefwindow id=d9430e4352 href="http://www.ncbi.nlm.nih.gov/pubmed/24776970">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4355 href="https://doi.org/10.1093/brain/awu079">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d9430e4364 class=n-a></a>Lauria G, Ziegler D, Malik R, <i> et al.</i>: The role of sodium channels in painful diabetic and idiopathic neuropathy. <i>Curr Diab Rep.</i> 2014; <b>14</b>(10): 538. <a target=xrefwindow id=d9430e4375 href="http://www.ncbi.nlm.nih.gov/pubmed/25142720">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4378 href="https://doi.org/10.1007/s11892-014-0538-5">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d9430e4388 class=n-a></a>Spallone V, Ziegler D, Freeman R, <i> et al.</i>: Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. <i>Diabetes Metab Res Rev.</i> 2011; <b>27</b>(7): 639–53. <a target=xrefwindow id=d9430e4399 href="http://www.ncbi.nlm.nih.gov/pubmed/21695768">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4402 href="https://doi.org/10.1002/dmrr.1239">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d9430e4411 class=n-a></a>Ziegler D, Voss A, Rathmann W, <i> et al.</i>: Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey. <i>Diabetologia.</i> 2015; <b>58</b>(5): 1118–28. <a target=xrefwindow id=d9430e4422 href="http://www.ncbi.nlm.nih.gov/pubmed/25724570">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4425 href="https://doi.org/10.1007/s00125-015-3534-7">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d9430e4434 class=n-a></a>Carnethon MR, Prineas RJ, Temprosa M, <i> et al.</i>: The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. <i>Diabetes Care.</i> 2006; <b>29</b>(4): 914–9. <a target=xrefwindow id=d9430e4445 href="http://www.ncbi.nlm.nih.gov/pubmed/16567837">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4448 href="https://doi.org/10.2337/diacare.29.04.06.dc05-1729">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4452 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1751934">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d9430e4461 class=n-a></a>Vinik AI, Maser RE, Mitchell BD, <i> et al.</i>: Diabetic Autonomic Neuropathy. <i>Diabetes Care.</i> 2003; <b>26</b>(5): 1553–79. <a target=xrefwindow id=d9430e4472 href="http://www.ncbi.nlm.nih.gov/pubmed/12716821">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4475 href="https://doi.org/10.2337/diacare.26.5.1553">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d9430e4484 class=n-a></a>Martin CL, Albers JW, Pop-Busui R, <i> et al.</i>: Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. <i>Diabetes Care.</i> 2014; <b>37</b>(1): 31–8. <a target=xrefwindow id=d9430e4495 href="http://www.ncbi.nlm.nih.gov/pubmed/24356595">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4498 href="https://doi.org/10.2337/dc13-2114">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4502 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3868000">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d9430e4511 class=n-a></a>Pop-Busui R, Low PA, Waberski BH, <i> et al.</i>: Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). <i>Circulation.</i> 2009; <b>119</b>(22): 2886–93. <a target=xrefwindow id=d9430e4522 href="http://www.ncbi.nlm.nih.gov/pubmed/19470886">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4525 href="https://doi.org/10.1161/CIRCULATIONAHA.108.837369">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2757005">Free Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d9430e4539 class=n-a></a>Low PA, Benrud-Larson LM, Sletten DM, <i> et al.</i>: Autonomic symptoms and diabetic neuropathy: a population-based study. <i>Diabetes Care.</i> 2004; <b>27</b>(12): 2942–7. <a target=xrefwindow id=d9430e4550 href="http://www.ncbi.nlm.nih.gov/pubmed/15562211">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4553 href="https://doi.org/10.2337/diacare.27.12.2942">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d9430e4562 class=n-a></a>Soedamah-Muthu SS, Chaturvedi N, Witte DR, <i> et al.</i>: Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). <i>Diabetes Care.</i> 2008; <b>31</b>(7): 1360–6. <a target=xrefwindow id=d9430e4573 href="http://www.ncbi.nlm.nih.gov/pubmed/18375412">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4576 href="https://doi.org/10.2337/dc08-0107">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4580 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2453640">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4961960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4589 class=n-a></a>Pop-Busui R, Evans GW, Gerstein HC, <i> et al.</i>: Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. <i>Diabetes Care.</i> 2010; <b>33</b>(7): 1578–84. <a target=xrefwindow id=d9430e4600 href="http://www.ncbi.nlm.nih.gov/pubmed/20215456">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4603 href="https://doi.org/10.2337/dc10-0125">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4607 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2890362">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4961960">F1000 Recommendation</a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d9430e4620 class=n-a></a>Maser RE, Mitchell BD, Vinik AI, <i> et al.</i>: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. <i>Diabetes Care.</i> 2003; <b>26</b>(6): 1895–901. <a target=xrefwindow id=d9430e4631 href="http://www.ncbi.nlm.nih.gov/pubmed/12766130">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4634 href="https://doi.org/10.2337/diacare.26.6.1895">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d9430e4643 class=n-a></a>Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. <i>Circulation.</i> 2007; <b>115</b>(3): 387–97. <a target=xrefwindow id=d9430e4651 href="http://www.ncbi.nlm.nih.gov/pubmed/17242296">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4654 href="https://doi.org/10.1161/CIRCULATIONAHA.106.634949">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d9430e4663 class=n-a></a>Dinh W, Füth R, Lankisch M, <i> et al.</i>: Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography. <i>Diabet Med.</i> 2011; <b>28</b>(3): 311–8. <a target=xrefwindow id=d9430e4674 href="http://www.ncbi.nlm.nih.gov/pubmed/21204960">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4677 href="https://doi.org/10.1111/j.1464-5491.2010.03221.x">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d9430e4687 class=n-a></a>Astrup AS, Tarnow L, Rossing P, <i> et al.</i>: Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. <i>Diabetes Care.</i> 2006; <b>29</b>(2): 334–9. <a target=xrefwindow id=d9430e4698 href="http://www.ncbi.nlm.nih.gov/pubmed/16443883">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4701 href="https://doi.org/10.2337/diacare.29.02.06.dc05-1242">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d9430e4710 class=n-a></a>Ziegler D, Keller J, Maier C, <i> et al.</i>: Diabetic neuropathy. <i>Exp Clin Endocrinol Diabetes.</i> 2014; <b>122</b>(7): 406–15. <a target=xrefwindow id=d9430e4721 href="http://www.ncbi.nlm.nih.gov/pubmed/25014092">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4724 href="https://doi.org/10.1055/s-0034-1366435">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d9430e4733 class=n-a></a>Mellegers MA, Furlan AD, Mailis A: Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. <i>Clin J Pain.</i> 2001; <b>17</b>(4): 284–95. <a target=xrefwindow id=d9430e4741 href="http://www.ncbi.nlm.nih.gov/pubmed/11783808">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4744 href="https://doi.org/10.1097/00002508-200112000-00002">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d9430e4753 class=n-a></a>Rudroju N, Bansal D, Talakokkula ST, <i> et al.</i>: Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis. <i>Pain Physician.</i> 2013; <b>16</b>(6): E705–14. <a target=xrefwindow id=d9430e4764 href="http://www.ncbi.nlm.nih.gov/pubmed/24284851">PubMed Abstract </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d9430e4773 class=n-a></a>Tanenberg RJ, Irving GA, Risser RC, <i> et al.</i>: Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. <i>Mayo Clin Proc.</i> 2011; <b>86</b>(7): 615–26. <a target=xrefwindow id=d9430e4784 href="http://www.ncbi.nlm.nih.gov/pubmed/21719618">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4787 href="https://doi.org/10.4065/mcp.2010.0681">Publisher Full Text </a> | <a target=xrefwindow id=d9430e4791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3127557">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d9430e4800 class=n-a></a>Goldstein DJ, Lu Y, Detke MJ, <i> et al.</i>: Duloxetine vs. placebo in patients with painful diabetic neuropathy. <i>Pain.</i> 2005; <b>116</b>(1–2): 109–18. <a target=xrefwindow id=d9430e4811 href="http://www.ncbi.nlm.nih.gov/pubmed/15927394">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4814 href="https://doi.org/10.1016/j.pain.2005.03.029">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d9430e4824 class=n-a></a>Wasan AD, Ossanna MJ, Raskin J, <i> et al.</i>: Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients. <i>Curr Drug Saf.</i> 2009; <b>4</b>(1): 22–9. <a target=xrefwindow id=d9430e4835 href="http://www.ncbi.nlm.nih.gov/pubmed/19149522">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4838 href="https://doi.org/10.2174/157488609787354404">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727671372"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4847 class=n-a></a>Trouvin AP, Perrot S, Lloret-Linares C: Efficacy of Venlafaxine in Neuropathic Pain: A Narrative Review of Optimized Treatment. <i>Clin Ther.</i> 2017; <b>39</b>(6): 1104–22. <a target=xrefwindow id=d9430e4855 href="http://www.ncbi.nlm.nih.gov/pubmed/28554532">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4858 href="https://doi.org/10.1016/j.clinthera.2017.05.347">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727671372">F1000 Recommendation</a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d9430e4871 class=n-a></a>Rowbotham MC, Goli V, Kunz NR, <i> et al.</i>: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. <i>Pain.</i> 2004; <b>110</b>(3): 697–706. <a target=xrefwindow id=d9430e4882 href="http://www.ncbi.nlm.nih.gov/pubmed/15288411">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4885 href="https://doi.org/10.1016/j.pain.2004.05.010">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d9430e4894 class=n-a></a>Markovits E, Gilhar A: Capsaicin--an effective topical treatment in pain. <i>Int J Dermatol.</i> 1997; <b>36</b>(6): 401–4. <a target=xrefwindow id=d9430e4902 href="http://www.ncbi.nlm.nih.gov/pubmed/9248881">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4905 href="https://doi.org/10.1046/j.1365-4362.1997.00102.x">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d9430e4914 class=n-a></a>Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. <i>Arch Intern Med.</i> 1991; <b>151</b>(11): 2225–9. <a target=xrefwindow id=d9430e4922 href="http://www.ncbi.nlm.nih.gov/pubmed/1953227">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4925 href="https://doi.org/10.1001/archinte.1991.00400110079017">Publisher Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d9430e4934 class=n-a></a>Polydefkis M, Hauer P, Sheth S, <i> et al.</i>: The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. <i>Brain.</i> 2004; <b>127</b>(Pt 7): 1606–15. <a target=xrefwindow id=d9430e4945 href="http://www.ncbi.nlm.nih.gov/pubmed/15128618">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4948 href="https://doi.org/10.1093/brain/awh175">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726017837"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e4958 class=n-a></a>Burness CB, McCormack PL: Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain. <i>Drugs.</i> 2016; <b>76</b>(1): 123–34. <a target=xrefwindow id=d9430e4966 href="http://www.ncbi.nlm.nih.gov/pubmed/26666418">PubMed Abstract </a> | <a target=xrefwindow id=d9430e4969 href="https://doi.org/10.1007/s40265-015-0520-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726017837">F1000 Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d9430e4982 class=n-a></a>Wolff RF, Bala MM, Westwood M, <i> et al.</i>: 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. <i>Swiss Med Wkly.</i> 2010; <b>140</b>(21–22): 297–306. <a target=xrefwindow id=d9430e4993 href="http://www.ncbi.nlm.nih.gov/pubmed/20458651">PubMed Abstract </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d9430e5002 class=n-a></a>Suarez GA, Opfer-Gehrking TL, Offord KP, <i> et al.</i>: The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. <i>Neurology.</i> 1999; <b>52</b>(3): 523–8. <a target=xrefwindow id=d9430e5013 href="http://www.ncbi.nlm.nih.gov/pubmed/10025781">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5016 href="https://doi.org/10.1212/WNL.52.3.523">Publisher Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d9430e5025 class=n-a></a>Freeman R: Autonomic peripheral neuropathy. <i>Lancet.</i> 2005; <b>365</b>(9466): 1259–70. <a target=xrefwindow id=d9430e5033 href="http://www.ncbi.nlm.nih.gov/pubmed/15811460">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5036 href="https://doi.org/10.1016/S0140-6736(05)74815-7">Publisher Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d9430e5045 class=n-a></a>Boulton AJM, Vinik AI, Arezzo JC, <i> et al.</i>: Diabetic neuropathies: a statement by the American Diabetes Association. <i>Diabetes Care.</i> 2005; <b>28</b>(4): 956–62. <a target=xrefwindow id=d9430e5056 href="http://www.ncbi.nlm.nih.gov/pubmed/15793206">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5059 href="https://doi.org/10.2337/diacare.28.4.956">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d9430e5068 class=n-a></a>Valensi P, Pariès J, Attali JR, <i> et al.</i>: Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study. <i>Metabolism.</i> 2003; <b>52</b>(7): 815–20. <a target=xrefwindow id=d9430e5079 href="http://www.ncbi.nlm.nih.gov/pubmed/12870154">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5082 href="https://doi.org/10.1016/S0026-0495(03)00095-7">Publisher Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d9430e5092 class=n-a></a>Witte DR, Tesfaye S, Chaturvedi N, <i> et al.</i>: Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. <i>Diabetologia.</i> 2005; <b>48</b>(1): 164–71. <a target=xrefwindow id=d9430e5103 href="http://www.ncbi.nlm.nih.gov/pubmed/15619072">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5106 href="https://doi.org/10.1007/s00125-004-1617-y">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d9430e5115 class=n-a></a>Charles M, Fleischer J, Witte DR, <i> et al.</i>: Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. <i>Diabetologia.</i> 2013; <b>56</b>(1): 101–8. <a target=xrefwindow id=d9430e5126 href="http://www.ncbi.nlm.nih.gov/pubmed/23064291">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5129 href="https://doi.org/10.1007/s00125-012-2744-5">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d9430e5138 class=n-a></a>Charles M, Ejskjaer N, Witte DR, <i> et al.</i>: Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. <i>Diabetes Care.</i> 2011; <b>34</b>(10): 2244–9. <a target=xrefwindow id=d9430e5149 href="http://www.ncbi.nlm.nih.gov/pubmed/21816977">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5152 href="https://doi.org/10.2337/dc11-0903">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5156 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3177734">Free Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d9430e5165 class=n-a></a>Ziegler D, Schatz H, Conrad F, <i> et al.</i>: Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. <i>Diabetes Care.</i> 1997; <b>20</b>(3): 369–73. <a target=xrefwindow id=d9430e5176 href="http://www.ncbi.nlm.nih.gov/pubmed/9051389">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5179 href="https://doi.org/10.2337/diacare.20.3.369">Publisher Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d9430e5188 class=n-a></a>Pop-Busui R, Stevens MJ, Raffel DM, <i> et al.</i>: Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. <i>Diabetologia.</i> 2013; <b>56</b>(8): 1835–44. <a target=xrefwindow id=d9430e5199 href="http://www.ncbi.nlm.nih.gov/pubmed/23740194">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5202 href="https://doi.org/10.1007/s00125-013-2942-9">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5206 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3730828">Free Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d9430e5215 class=n-a></a>Pop-Busui R: Cardiac autonomic neuropathy in diabetes: a clinical perspective. <i>Diabetes Care.</i> 2010; <b>33</b>(2): 434–41. <a target=xrefwindow id=d9430e5223 href="http://www.ncbi.nlm.nih.gov/pubmed/20103559">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5226 href="https://doi.org/10.2337/dc09-1294">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5229 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2809298">Free Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d9430e5239 class=n-a></a>Freeman R, Abuzinadah AR, Gibbons C, <i> et al.</i>: Orthostatic Hypotension: <i>JACC</i> State-of-the-Art Review. <i>J Am Coll Cardiol.</i> 2018; <b>72</b>(11): 1294–309. <a target=xrefwindow id=d9430e5253 href="http://www.ncbi.nlm.nih.gov/pubmed/30190008">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5257 href="https://doi.org/10.1016/j.jacc.2018.05.079">Publisher Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a name=d9430e5266 class=n-a></a>Gibbons CH, Schmidt P, Biaggioni I, <i> et al.</i>: The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. <i>J Neurol.</i> 2017; <b>264</b>(8): 1567–82. <a target=xrefwindow id=d9430e5277 href="http://www.ncbi.nlm.nih.gov/pubmed/28050656">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5280 href="https://doi.org/10.1007/s00415-016-8375-x">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5284 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5533816">Free Full Text </a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d9430e5293 class=n-a></a>Freeman R: Clinical practice. Neurogenic orthostatic hypotension. <i>N Engl J Med.</i> 2008; <b>358</b>(6): 615–24. <a target=xrefwindow id=d9430e5301 href="http://www.ncbi.nlm.nih.gov/pubmed/18256396">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5304 href="https://doi.org/10.1056/NEJMcp074189">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d9430e5313 class=n-a></a>Kaufmann H: Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn? <i>Clin Auton Res.</i> 2017; <b>27</b>(Suppl 1): 1–3. <a target=xrefwindow id=d9430e5321 href="http://www.ncbi.nlm.nih.gov/pubmed/28623419">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5324 href="https://doi.org/10.1007/s10286-017-0426-6">Publisher Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d9430e5333 class=n-a></a>Parkman HP, Hasler WL, Fisher RS: American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. <i>Gastroenterology.</i> 2004; <b>127</b>(5): 1592–622. <a target=xrefwindow id=d9430e5341 href="http://www.ncbi.nlm.nih.gov/pubmed/15521026">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5344 href="https://doi.org/10.1053/j.gastro.2004.09.055">Publisher Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d9430e5353 class=n-a></a>Kumar M, Chapman A, Javed S, <i> et al.</i>: The Investigation and Treatment of Diabetic Gastroparesis. <i>Clin Ther.</i> 2018; <b>40</b>(6): 850–61. <a target=xrefwindow id=d9430e5364 href="http://www.ncbi.nlm.nih.gov/pubmed/29748143">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5367 href="https://doi.org/10.1016/j.clinthera.2018.04.012">Publisher Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d9430e5377 class=n-a></a>Murao S, Hosokawa H: Serotonin 5-HT3 receptor antagonist for treatment of severe diabetic diarrhea. <i>Diabetes Care.</i> 2010; <b>33</b>(3): e38. <a target=xrefwindow id=d9430e5385 href="http://www.ncbi.nlm.nih.gov/pubmed/20190286">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5388 href="https://doi.org/10.2337/dc09-2131">Publisher Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d9430e5397 class=n-a></a>Ogbonnaya KI, Arem R: Diabetic diarrhea. Pathophysiology, diagnosis, and management. <i>Arch Intern Med.</i> 1990; <b>150</b>(2): 262–7. <a target=xrefwindow id=d9430e5405 href="http://www.ncbi.nlm.nih.gov/pubmed/2405798">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5408 href="https://doi.org/10.1001/archinte.1990.00390140018005">Publisher Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d9430e5417 class=n-a></a>Feldman HA, Goldstein I, Hatzichristou DG, <i> et al.</i>: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. <i>J Urol.</i> 1994; <b>151</b>(1): 54–61. <a target=xrefwindow id=d9430e5428 href="http://www.ncbi.nlm.nih.gov/pubmed/8254833">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5431 href="https://doi.org/10.1016/S0022-5347(17)34871-1">Publisher Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d9430e5440 class=n-a></a>Azmi S, Ferdousi M, Alam U, <i> et al.</i>: Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study. <i>Diabetologia.</i> 2017; <b>60</b>(6): 1094–101. <a target=xrefwindow id=d9430e5451 href="http://www.ncbi.nlm.nih.gov/pubmed/28357503">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5454 href="https://doi.org/10.1007/s00125-017-4245-z">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5458 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5423985">Free Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a name=d9430e5467 class=n-a></a>Giugliano F, Maiorino M, Bellastella G, <i> et al.</i>: Determinants of erectile dysfunction in type 2 diabetes. <i>Int J Impot Res.</i> 2010; <b>22</b>(3): 204–9. <a target=xrefwindow id=d9430e5478 href="http://www.ncbi.nlm.nih.gov/pubmed/20147958">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5481 href="https://doi.org/10.1038/ijir.2010.1">Publisher Full Text </a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a name=d9430e5490 class=n-a></a>van den Eeden SK, Sarma AV, Rutledge BN, <i> et al.</i>: Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. <i>Diabetes Care.</i> 2009; <b>32</b>(4): 664–70. <a target=xrefwindow id=d9430e5501 href="http://www.ncbi.nlm.nih.gov/pubmed/19171725">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5504 href="https://doi.org/10.2337/dc07-2375">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5508 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2660483">Free Full Text </a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d9430e5518 class=n-a></a>Enzlin P, Mathieu C, van den Bruel A, <i> et al.</i>: Sexual dysfunction in women with type 1 diabetes: a controlled study. <i>Diabetes Care.</i> 2002; <b>25</b>(4): 672–7. <a target=xrefwindow id=d9430e5529 href="http://www.ncbi.nlm.nih.gov/pubmed/11919123">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5532 href="https://doi.org/10.2337/diacare.25.4.672">Publisher Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732868819"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5541 class=n-a></a>Hackett G, Kirby M, Wylie K, <i> et al.</i>: British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction in Men-2017. <i>J Sex Med.</i> 2018; <b>15</b>(4): 430–57. <a target=xrefwindow id=d9430e5552 href="http://www.ncbi.nlm.nih.gov/pubmed/29550461">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5555 href="https://doi.org/10.1016/j.jsxm.2018.01.023">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732868819">F1000 Recommendation</a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733715277"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5568 class=n-a></a>Mulhall JP, Giraldi A, Hackett G, <i> et al.</i>: The 2018 Revision to the Process of Care Model for Evaluation of Erectile Dysfunction. <i>J Sex Med.</i> 2018; <b>15</b>(9): 1280–92. <a target=xrefwindow id=d9430e5579 href="http://www.ncbi.nlm.nih.gov/pubmed/30057280">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5582 href="https://doi.org/10.1016/j.jsxm.2018.06.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733715277">F1000 Recommendation</a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733715278"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5595 class=n-a></a>Mulhall JP, Giraldi A, Hackett G, <i> et al.</i>: The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction. <i>J Sex Med.</i> 2018; <b>15</b>(10): 1434–45. <a target=xrefwindow id=d9430e5606 href="http://www.ncbi.nlm.nih.gov/pubmed/30057278">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5609 href="https://doi.org/10.1016/j.jsxm.2018.05.021">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733715278">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733230893"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5622 class=n-a></a>Mulhall JP, Carlsson M, Stecher V, <i> et al.</i>: Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo. <i>J Sex Med.</i> 2018; <b>15</b>(6): 866–72. <a target=xrefwindow id=d9430e5633 href="http://www.ncbi.nlm.nih.gov/pubmed/29753799">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5636 href="https://doi.org/10.1016/j.jsxm.2018.03.089">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733230893">F1000 Recommendation</a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d9430e5649 class=n-a></a>Gruenwald I, Kitrey ND, Appel B, <i> et al.</i>: Low-Intensity Extracorporeal Shock Wave Therapy in Vascular Disease and Erectile Dysfunction: Theory and Outcomes. <i>Sex Med Rev.</i> 2013; <b>1</b>(2): 83–90. <a target=xrefwindow id=d9430e5660 href="http://www.ncbi.nlm.nih.gov/pubmed/27784587">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5663 href="https://doi.org/10.1002/smrj.9">Publisher Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732757171"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5673 class=n-a></a>Kitrey ND, Vardi Y, Appel B, <i> et al.</i>: Low Intensity Shock Wave Treatment for Erectile Dysfunction-How Long Does the Effect Last? <i>J Urol.</i> 2018; <b>200</b>(1): 167–70. <a target=xrefwindow id=d9430e5684 href="http://www.ncbi.nlm.nih.gov/pubmed/29477719">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5687 href="https://doi.org/10.1016/j.juro.2018.02.070">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732757171">F1000 Recommendation</a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726594652"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5700 class=n-a></a>Bechara A, Casabé A, De Bonis W, <i> et al.</i>: Twelve-Month Efficacy and Safety of Low-Intensity Shockwave Therapy for Erectile Dysfunction in Patients Who Do Not Respond to Phosphodiesterase Type 5 Inhibitors. <i>Sex Med.</i> 2016; <b>4</b>(4): e225–e232. <a target=xrefwindow id=d9430e5711 href="http://www.ncbi.nlm.nih.gov/pubmed/27444215">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5714 href="https://doi.org/10.1016/j.esxm.2016.06.001">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5121537">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726594652">F1000 Recommendation</a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735008221"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d9430e5731 class=n-a></a>Elhanbly SM, Abdel-Gawad MM, Elkholy AA, <i> et al.</i>: Nocturnal penile erections: A retrospective study of the role of RigiScan in predicting the response to sildenafil in erectile dysfunction patients. <i>J Adv Res.</i> 2018; <b>14</b>: 93–6. <a target=xrefwindow id=d9430e5742 href="http://www.ncbi.nlm.nih.gov/pubmed/30109146">PubMed Abstract </a> | <a target=xrefwindow id=d9430e5745 href="https://doi.org/10.1016/j.jare.2018.06.002">Publisher Full Text </a> | <a target=xrefwindow id=d9430e5749 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6090085">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735008221">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 15 Feb 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-186/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-186/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Institute of Cardiovascular Sciences, University of Manchester and Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK<br/> <sup>2</sup> Manchester Diabetes Centre, Manchester University Foundation Trust, Manchester, UK<br/> <sup>3</sup> Weill Cornell Medicine-Qatar, Education City, Qatar Foundation, Doha, Qatar<br/> <sup>4</sup> Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK<br/> <sup>5</sup> Department of Diabetes and Endocrinology, Royal Liverpool and Broadgreen University NHS Hospital Trust, Liverpool, UK<br/> <p> <div class=margin-bottom> Shazli Azmi <br/> <span>Roles: </span> Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ioannis N. Petropoulos <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Maryam Ferdousi <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Georgios Ponirakis <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Uazman Alam <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Rayaz A. Malik <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-186/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 15 Feb 2019, 8:186 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.17118.1">https://doi.org/10.12688/f1000research.17118.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Azmi S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=18716 data-id=17118 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17118.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-186/v1/pdf?article_uuid=68f0bdfe-59f8-4901-9dc0-b8f205eab4cd" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.17118.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Azmi S, Petropoulos IN, Ferdousi M <em>et al.</em> An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy [version 1; peer review: 3 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):186 (<a href="https://doi.org/10.12688/f1000research.17118.1" target=_blank>https://doi.org/10.12688/f1000research.17118.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=17118 id=mobile-track-article-signin-17118 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17118?target=/articles/8-186/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18716 /> <input name=articleId type=hidden value=17118 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Mark Yorek</strong>, Department of Internal Medicine, University of Iowa, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Simone E. Baltrusch</strong>, Institute of Medical Biochemistry and Molecular Biology, University of Rostock, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Zheng Gang Zhang</strong>, Department of Neurology, Henry Ford Hospital, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 15 Feb 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-186/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-186/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=45773-44099></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=45774-44098></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=45775-44097></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-186/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>15 Feb 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Mark Yorek</strong>, Department of Internal Medicine, University of Iowa, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Simone E. Baltrusch</strong>, Institute of Medical Biochemistry and Molecular Biology, University of Rostock, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Zheng Gang Zhang</strong>, Department of Neurology, Henry Ford Hospital, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-186/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-186/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "An update on the diagnosis and treatment...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-186/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-186/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-186/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Azmi S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-186/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-186",
            templates : {
                twitter : "An update on the diagnosis and treatment of diabetic somatic.... Azmi S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-186/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/17118/18716")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "18716");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "44097": 0,
                           "44098": 0,
                           "44099": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "c39fd217-8f1e-4972-a901-daeed970f4ce";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-186.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-186.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-186.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-186.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-186.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>